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The overall aim of this thesis is to analyse the interaction sites on collagen type 1 with FN to gain new detailed structural insights into their interactions. Fibronectin (FN) and collagen belong to the most abundant members of the extracellular matrix and play important  roles  in  growth,  development,  repair,  and  cancerous  tumour  progression (Kleinman  and McGoodwin  1976;  Barilla  and  Carsons  2000;  Perumal,  Antipova  et  al. 2008).  Although  their  interaction  has  been  mentioned  in  literature  as  early  as  1977 (Engvall  and  Ruoslahti  1977;  Dessau,  Sasse  et  al.  1978;  Kleinman,  McGoodwin  et  al. 1978), until recently no structure of the complex has been available, and thus, details of this interactions have remained unclear.  Recently,  Erat  et  al.  showed  that  the  collagen  type  1  α1  chain  makes  a  tight complex  with  the  42  kDa  gelatin‐binding  domain  (GDB)  in  FN  by  solving  the  X‐ray structure  of  a  complex  of  8‐9FnI  bound  to  a  collagen  peptide  of  23  amino  acids  to  a resolution of 2.1Å (Erat, Slatter et al. 2009). Collagen type 1 consists of two α1 and one 
α2  chain.  By  looking  closer  onto  collagen  type 1,  two  interaction  sites were  found on each α chain, called collagenase‐site and 260‐site.  We found out that the interaction of FN with collagenase‐site is tighter than with the 260‐site. The reason for that is that the starting‐sequence for the collagenase‐site, in both  chains,  is  more  hydrophobic  and  therefore  it  is  more  suitable  for  interaction. According to the collected data it is easy to see that the so‐called 260‐site‐α2, undergoes weak binding with 8‐9FnI. Furthermore, we report a defined  interaction of  8‐9FnI with  the 260‐site  (G254 – Y277) of collagen type 1 α1 chain. This was characterised using NMR and X‐ray. We were able to crystallise the interaction complex at a resolution of 2.6Å. The structure was then determined by using molecular  replacement. The overall  conformation of  the  collagen type  1  260‐site‐α1  peptide  is  similar  to  the  one  with  the  collagenase‐site‐α1  (Erat, Slatter et al. 2009). The main differences between these two structures are two valines, which are interacting with 9FnI. Closer examination showed that these two valines, V782 and V783,  are  responsible  for  the  tight  interaction of  8‐9FnI with  the collagenase‐site  in collagen  type  1.  These  two  residues  cannot  be  detected  at  any  of  the  260‐sites  in collagen type 1. So our conclusion is that it is a sequential phenomenon. 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Figure  4.6: NMR HSQC  spectrum of  the  titration  8‐9FnI with  collagen  type 1  260‐site‐α2  (core sequence)  Figure 4.7: NMR‐spectrum of the interaction between 8‐9FnI with collagen type1 260‐site‐α1 Figure 4.8: a) zoom in, where you can see that a fast exchange is happening b) shift differences between 0.0mM and 1mM of the collagen type 1 α1 ‐260‐site of I522 Figure 4.9: Origin data for the 8‐9FnI in interaction with collagen type1 260‐site‐α1 Figure 4.10: shifting peaks on the 8‐9FnI Figure 4.11: X‐ray data collection and refinement statistics for 8‐9FnI collagen type 1 260‐site‐α1 (G254 – Y277) complex Figure 4.12: a general view of the Ramachandran plot Figure 4.13: Ramachandran plot of the collagen type1 α1 in complex with 8‐9 FnI Figure 4.14: 8‐9FnI Figure 4.15 Overview of the interaction structure Figure 4.16: interaction of ‐9FnI in complex with collagen type 1 260‐site‐α1 (G254 – Y277) Figure 4.17: 4‐Hydroxy‐L‐Prolines in Collagen type1 α1 ‐260 binding site Figure 4.18: HYP  in collagen type 1 260‐site‐α1 peptide,  related with  the surface of  the whole interaction complex Figure 4.19: Glycosylation site on N542 with NAG Figure 4.20: Looking at the surface of the FN collagen peptide complex Figure 4.21: Disulfide bridges on the 8‐9FN shown in orange                 Figure 4.22: Density map of one asymmetric unit  Figure 4.23: Surface view of the 8‐9FnI in complex with collagen type 1 260‐site‐α1  Figure 4.24: NMR HSQC spectrum of the titration 8‐9FnI with collagen type 1 collagenase‐site‐α1 (G778‐G799) Figure 4.25: Kd‐values of the fluorescence anisotropy measurement Figure 4.26: Origin data of the fluorescence anisotropy titration of collagen type 1 collagenase‐site‐α1 and 8‐9FnI Figure 4.27: NMR HSQC spectrum of the titration 8‐9FnI with collagen type 1 collagenase‐site‐α1 (G778‐G799) with the VS‐mutation Figure 4.28: NMR HSQC spectrum of the titration 8‐9FnI with collagen type 1 collagense‐site‐α1 (G778‐G799) with the SV‐mutation 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The extracellular matrix (ECM) is a highly organized multi‐molecular network of proteoglycans,  fibrous  proteins  and polysaccharides  that  provides  structural support  in  mammalian  tissues. Furthermore,  it  gives  a  dynamic microenvironment  for  cell  adhesion, differentiation,  and  proliferation  (Raines 2000).  ECM  proteins  such  as  FN,  elastin, lamines  or  collagen  form  distinct  protein networks. This matrix  shows  tissue specific variation  in composition and architecture (Mao and Schwarzbauer 2005). These  large, multi‐domain  proteins  allow  the  ECM  to  keep  its  structure,  while  being  elastic  and flexible (Sivakumar, Czirok et al. 2006). Variation in the relative amounts of the different types of matrix macromolecules  and  the way  in which  they  are organized  in  the ECM lead to an amazing diversity of forms, each adapted to the functional requirements of the particular tissue (The Cell, Alberts, p. 1090ff). A model of the ECM is shown in Figure 1.1. 
1.1.1. Fibronectin – a modular protein 
FN was first discovered by Morrison, Edsall and Miller in 1948 (Morrison, Edsall et  al. 1948), while purifying human  fibrinogen  from blood plasma. FN  is a  large  (400‐500kDa)  multifunctional,  adhesive  glycoprotein  found  as  a  soluble  dimer  in  blood plasma  and  as  an  insoluble multimer  in  the  basal membrane  and  extracellular matrix (ECM) (Ruoslahti, Pekkala et al. 1979; Ruoslahti 1988). A single gene that is alternatively 
Figure  1.1:  Model  of  the  extracellular Matrix (The Cell, Alberts, p. 1090) A various of cells and extracellular matrix components is shown here. 




 spliced  at  three  sites  encodes  for  FN,  which  then  Fibroblasts,  Schwann  cells, chondrocytes,  myoblasts,  macrophages,  hepatocytes  and  intestinal  epithelial  cells synthesise. FN is one of the most ubiquitous components of the ECM. FN appears in two major  forms,  the  cellular  FN  and  plasma  FN  (Rovin, Molnar  et  al.  1984).  As  a  soluble dimer  FN  is  involved  in  blood  coagulation  through  its  affinity  for  fibrin  and  platelets (Hynes 1985). The cellular FN is actively organised into a detergent‐insoluble network where it forms fibrils (Magnusson and Mosher 1998). The resulting matrix is important for  normal  cell  adhesion,  growth  and  assists  cell  migration  and  the  maintenance  of tissue  integrity,  while  interacting  with  cell  surface  receptors  and  with  other  matrix components, such as collagen and proteoglycans (Pickford, Smith et al. 2001).  
1.1.2. Structural studies of fibronectin modules  
Many  different  cell  types  synthesize  FN  and  secrete  it  as  a  disulfide‐bonded homodimer  composed  of  230‐270  kDa  subunits  (Mao  and  Schwarzbauer  2005).  This mosaic  protein  is  assumed  to  be  rod‐like,  composed  of  three  different  types  of homologous,  repeating  modules  (Kornblihtt,  Umezawa  et  al.  1985).  Each  FN  subunit contains three types of repeating modules, type I, II and III, shown in Figure 1.2. Theses modules are composed of  functional domains that mediate  interaction with other ECM components,  with  cell  surface  receptors  and  with  FN  itself.  Type  I  and  II  modules contain  two  intra‐chain  disulfide  bonds,  which  are  important  for  the  stability  and function  of  these  modules  (Williams,  Phan  et  al.  1994).  Each  module  constitutes  an independently folded unit. The amino acid sequences are highly conserved in the core. In contrast, residues, which are exposed to the solvent, are variable and predominantly hydrophilic (Potts and Campbell 1994).  





  There are 12 FnI modules in total, clustered in three groups. Furthermore, there are two adjacent FnII modules, each 60 amino acid long and 15‐17 FnIII, each about 90 amino acids long (Rostagno, Williams et al. 1994). The two FnII modules are adjacent to FnI. FnIII  is  the most common module  in FN.  It contains  the RGD receptor recognition sequence along with binding sites for other integrins and heparin (Potts and Campbell 1996). 
1.1.2.1 Structure of FN Type I  
Each  of  the  type  I modules  of  FN  (FnI)  is made  up  of  approximately  45  amino acids with four cysteine residues forming two disulfide bonds. The FnI module was first identified  in  FN  and  has  since  been  found  in  a  number  of  other  proteins,  including tissue‐type  plasminogen  activator  (t‐PA),  the  blood  coagulation  factor  XII  (McMullen and Fujikawa 1985) and hepatocyte growth factor activator (Potts and Campbell 1996). 
 
Figure 1.2: Domain structure and modules of human FN, including the alternatively spliced EDB, EDA, and IIICS regions and the dimerization site. Every  single FnI  fragment hast 2 disulfide bridges,  the FnII domain has 2 disulfide bridges and FnIII has no disulfide bridge. 




 The  fist  five  N‐terminal  FnI  modules  (∼29  kDa)  are  called  “FN‐fingers” (Novokhatny  and  Ingham 1994). These  1‐5FnI  repeats  are  essential  for ECM assembly. Deletion  of  any  of  these  five  FnI modules  prevents  FN  from  contributing  to  the  ECM, because  the  affinity  of  the  N‐terminal  domain  for  cellular  FN  assembly  site  becomes significantly  reduced  (Williams, Phan et  al.  1994; Meenan, Visai  et  al.  2007). The  “FN‐fingers” and the 10‐12FnI modules are involved in fibrin binding during tthe formation of blood  clots.  1‐5FI  also  contains  binding‐sites  for  heparin,  thrombospondin,  tumour necrosis  factor‐α  and  surface  proteins  of  pathogenic  bacteria  such  as  Staphylococcus 
aureus.   Finally  the 6‐9FnI modules,  that surround the two FnII modules,  assist  in  collagen  binding  and  contribute  to  ECM assembly.  (Potts  and  Campbell  1994).  The  fold  of  the  FnI module  is  shown  in  Figure  1.3.  The  top  sheet  is made up  of two  anti‐parallel  β‐strands,  and  folds  over  a  bottom  sheet, composed  of  three  anti‐parallel  β‐strands.  Two  conserved disulfide bonds hold the two sheets together.   The module  is stabilised  through  the  sheets’  hydrophobic  interactions  The FnI core contains two conserved disulfide bonds. The 1‐3 S‐S bond links the two strands of the top sheet, – while the 2‐4 S‐S bond  links  the  top  and  the  bottom  sheets  and  hence  stabilises  the  fold.  A  salt  bridge connects  a  conserved  negatively  asparactic  acid  and  a  conserved  positively  charged residue,  which  can  be  an  arginine,  in  strand  C  again  stabilising  the  fold  (Potts  and Campbell 1996).  
 
Figure  1.3:  The  ∼29 kDa FnI module, which consists  out  of  two anti‐parallel  β‐strands and  has  two  disulfide bridges 






FN  is  essential  for  the  structure  and  organisation  of  mammalian  tissues.  Cell adhesion to FN via integrins and other cell surface receptors is necessary in anchorage‐dependent  cell  growth  and  proliferation,  differentiation  and  matrix  assembly  (Hynes 1985). Moreover, FN plays important role in  a) connective tissue                    b) blood                                                      c) wound healing                    d) fibril formation  
a) Connective tissue Connective tissue is any supporting fibrous tissue that lies between other tissues and consists of  cells  embedded  in a  relatively  large amount of  the ECM,  such as bone, cartilage  and  epithelial  cell  basement  membrane.  It  forms  the  framework  of  the vertebrate body with the main role including cellular support, defence, communication and  nutrition.  FN  and  collagen  are  the  main  proteins  of  connective  tissue.  (The  Cell, Alberts, p.1091).  
b) The blood Blood  is  a  specialized  body  fluid  that  plays  an  essential  role  in  regulation  and defence  as  well  as  in  transporting  necessary  substances  through  the  body.  Blood consists  of  cells  suspended  in plasma.  FN  in blood  is  involved  in blood  clot  formation and  the  early  stage  of  wound  healing  and  in  opsonisation  (Mosher  and  Schad  1979; Kilis‐Pstrusinska, Wikiera‐Magott et al. 2002). 
c) Wound healing Wound  healing  is  the  body’s  natural  process  if  regenerating  dermal  and epidermal  tissue.  During  this  process  platelets  bind  to  exposed  collagen  at  the  site  of 




 tissue  damage  (The  Cell,  Alberts  p.1092;  (Taylor  and  Gartner  1992).  After  release  of products from the activated platelets several proteolytic reactions start, which result in the activation of  thrombin and can be summed up as  inflammation. FN modulates cell migration,  which  is  the  next  stage  of  the  healing  process.  This  proliferative  phase  is characterized  by  angiogenesis,  collagen  deposition,  granulation  tissue  formation, epithelialisation,  and  wound  contraction  (Midwood,  Valenick  et  al.  2004).  During epithelialisation, epithelial cells crawl across the wound bed to cover it. Myofibroblasts make  the  wound  smaller.  During  the  maturation  and  remodelling  phase,  collagen  is remodelled  and  realigned  along  tension  lines  and  cells  that  are  no  longer  needed  are removed by apoptosis (Gabbiani 2003).  
d) Fibril formation Fibril  formation  is  the  process  in which  FN  is  initially  organized  into  fine  cell‐associated fibrils (Schwarzbauer and Sechler 1999). Figure 1.4 shows the crucial steps. The  ability  to  control  this  process  is  important,  otherwise  FN  would  aggregate spontaneously  in  the  blood  (Dzamba  and  Peters  1991;  Granelli‐Piperno,  Moser  et  al. 1996). Moreover, this process is necessary for FN’s own regulation and turnover as well as  the maintenance  of  other  ECM  components  such  as  collagen  and  thrombospondin (Sottile and Hocking 2002). Fibril formation, the initiation step of matrix assembly, requires a conserved RGD (Arg‐Gly‐Asp)‐sequence  within  FN.  FN  binds  to  integrin  receptors  and  to  collagen. Integrin‐bound FN  is diffusely  localized at  the  cell  surface  (Johnson,  Sage et  al.  1999). During assembly, longer and thicker fibrils are formed (Sottile and Hocking 2002). The size of the resulting FN fibrils varies between 5nm and 18nm diameter with spaced out repeats  ranging  from  84nm  and  168nm  in  the  thin  fibril  to  42nm  in  the  thick  fibril. (Dzamba, Wu et al. 1993; Sechler, Takada et al. 1996; Sechler, Rao et al. 2001). 





  Figure  1.5  shows  a  schematic  representation  of  the  main  steps  in  this  cell‐mediated process (Geiger, Bershadsky et al. 2001).  
  
 
Figure 1.4: Crucial steps in FN fibril assembly (A) Compact soluble FN binds to integrin α5β1 via its cell binding domain, (B) FN binding to  integrins  and  other  receptors  induces  reorganisation  of  the  actin  cytoskelton  and activates  intracellular  signalling  complexes.  (C)  Fibrils  form  through  FN‐FN  interactions. (Mao and Schwarzbauer 2005) 
 
Figure 1.5: A schematic representation of the main steps in Fibrillogenesis (Geiger, Bershadsky et al. 2001)   






Collagen  is  the  main  protein  of  connective  tissue  in  animals  and  the  most abundant  protein  in  mammals.  It  makes  up  about  25%  of  the  whole‐body  protein content.  The  collagen  family  is  a  superfamily  of  extracellular  matrix  fibrous  proteins found  in  all  multicellular  animals,  where  it  defines  mechanical  properties  of  tissues (Rich and Crick 1961; Ramachandran 1963; van der Rest and Garrone 1991; Leitinger and Hohenester 2007; Brodsky and Baum 2008). It  is the main component of tendons, ligaments,  bone  and  teeth  and  responsible  for  the  remarkable  strength,  stability  and elasticity  of  the  skin.  Furthermore,  it  is  intimately  involved  in  cell  adhesion  and migration,  as  well  as  differentiation,  morphogenesis  and  wound  healing.  So,  it  is  not surprising that many human diseases have their origin in mutations within the collagen genes (Eyre 1980; Leitinger and Hohenester 2007).  Over 30 collagen types have been identified so far, the most important ones are listed in the table in Figure 1.6 below (Gelse, Poschl et al. 2003). Types I, II and III are the most abundant collagens, forming characteristic fibrils with identifiable repeat bands in the structure separated by 67nm (Vakonakis and Campbell 2007). This periodic pattern is very specific for the individual collagen types and consists of sequential triples. This is explained in more detail in chapter 1.2.3. The different collagen types vary in the exact primary sequence and the identity of the three strands of the tropocollagen coiled‐coil.    






Collagen type  Name  Role  Location Fibril forming  I  provides tensile strength and torsinoal stiffness  scar tissue, tendons, skin, artery  walls, endomysium  of myofibrils,  fibrocartilage, bones, teeth   II  is  the  basis  for  articular cartilage  and  hyaline cartilage  cartilage   III  commonly  found  alongside type I  granulation tissue, artery walls, skin, intestines, the uterus   V  most  interstitial  tissue, associated with type I as well as with placenta  placenta Basement membrane collagen  IV  forms bases of  cell basement membrane and serves as part of  the  filtration  system  in capillaries  and  the  glomeruli of nephron in the kidney 
basal lamina; eye lens 
Micorfibrillare collagen  VI  associates with type I  interstitial tissue, dermis, cartilage, lungs, vessel Anchoring fibrils  VII  forms  anchoring  fibrils  in dermal epidermal junctions  dermis Hexagonal network  forming collagens  VIII  some endothelial cells     X  hypertrophic  and mineralizing cartilage   Fibril  associated collagens  XI  forms  heterotypic  narrow fibrils  with  collagen  type  II and  type  IX,  mainly  in cartilaginous,  the  ratio between collagen  type  II  and type XI in cartilage is 1:30 
 
  XII  interacts  with  type  I containing  fibrils,  decorin and glycosaminoglycans   Transmembrane collagen  XIII  interacts with  integrin α1β1, FN  and  components  of basement membranes    
Figure 1.6: List of the most important collagen types (adapted from Gelse, Poschl et al. 2003) 






Collagen consists of  a  long  stiff  triple‐stranded helical  structure,  in which  three collagen‐polypeptide  chains  are wound  around  one  another  in  a  rope‐like  superhelix, which  is  approximately  300  nm  long  and  1.5  nm  in  diameter.  This  superhelix  is  also called  tropocollagen  or  "collagen  molecule".  One  tropocollagen  helix  of  collagen  is shown  in  Figure  1.7.  Five  tropcollagen  helices  together  form  one  microfibril.  The microfibrils  are  then  combined  to  form  fibrous  collagen. At  this  stage  collagen  is  very rigid  and  tightly  connected  to  each  other,  so  that  it  is  impossible  to  isolate  them individually  (The  Cell,  Alberts,  p.  1091ff).  Figure  1.7  shows  a  model  of  a  collagen’s typical molecular structure.  
 
 
Figure  1.7:  Collagen’s  molecular  structure.  The  strucutre  is  made  out  of  a  long  stiff  triple‐stranded helical  structure, which are  then wounded around  into a  rope‐like  superhelix,  called tropocollagen. Five tropcollagen helices form one microfibril. (realted to http://www.bio.miami.edu/~cmallery/150/physiol/40x2collagen.gif)   






1.2.2. A typical triple helical region characterizes every collagen molecule. Most of the collagens consist of two α1 and one α2 chain. Each individual chain forms a left‐handed helix with  a  pitch  of  18  amino  acids  per  turn.  The  three  chains  are  staggered  by  one amino acid residue relative to each other (Figure 1.8). Three left‐handed helices are then twisted  together  into  a  right‐handed  coiled  coil,  (Khew  and  Tong  2007).  The  triple helical  region  is  characterised by  a  three  residue‐repeat  in  its  primary  structure. This tripeptide repeat is the predominating motif in fibril‐forming collagens, which result in triple  helical  domains  of  300nm  in  length  ‐  approximately 1000  amino  acids.  The  sequence‐pattern  is  Gly‐Pro‐  Yaa  or Gly‐Xaa  ‐Hyp,  where  X  and  Y  may  be  any  of  various  other amino  acid  residues  (Pro  =  Proline, Hyp  = Hydroxyproline) (Monti, Bronco et al. 2005; Okuyama 2008).    Pro  and  Gly  are  both  important  for  the  formation  of the  triple‐helical  structure  of  tropocollagen.  Glycine  is  the smallest  amino  acid  and  is  required  at  every  third  residue throughout  the  core  region  of  the α  chain.  The  triple  helix puts this residue at the interior of the helix, where there is no space  for  a  larger  side  group  than  the  glycine’s  single hydrogen atom (Wang, Mo et al. 2005). Furthermore the high content of the imino acids, Pro and Hyp, force a high degree in steric restriction. This helps to stabilize the helical conformation of  the α‐chain  (Nagarajan, Kamitori et al. 1999). A cylinder of hydration surrounds every triple helix (Monti, Bronco et al. 2005).  
 
Figure  1.8:  Collagen’s triple  helical  structure (http://www.new‐science‐press.com) 




 The  hydroxylation  on  Pro  residues  at  the  Y  position  helps  the  formation  of intramolecular hydrogen bonds. This then leads to a higher stability of the triple helical conformation (Gelse, Poschl et al. 2003).  For  the  most  stable  conformation  of  the  triple  helical  structure  the  best composition would be Gly‐Pro‐YAA, here YAA  is a Hyp, Arg, Met,  Ile, Gln or Ala  (Raman, Parthasarathi et al. 2006).  
1.2.1. Collagen type 1 
 Collagen  type  I  is a structural component  in most connective  tissues, and  is  the only component of the collagen found in cartilage. It has two α1 and one α2 chain and is abundant  in bone,  cornea, dermis  and  tendon  (Figure 1.9). Mutations  in  this  gene  can lead to osteogenesis imperfecta types I‐IV, Ehlers‐Danlos syndrome, Caffey Disease and idiopathic osteoporosis (Kuivaniemi, Tromp et al. 1991; Kuivaniemi, Tromp et al. 1997; Rossert, Terraz et al. 2000). The  COL1A1  gene  codes  for  the  pro‐α1  chain  (Solomon,  Hiorns  et  al.  1984; Sengupta, Xu et al. 2005). This chain combines with another pro‐α 1 chain and also with a pro‐α2 chain, which is produced by the COL1A2 gene, to make a molecule of type I pro‐collagen. These triple‐stranded, rope‐like pro‐collagen molecules must be processed by enzymes outside the cell. Once these molecules are processed, they arrange themselves 
 
Figure 1.9: Collagen type 1 (Brodsky and Baum 2008) consists out of two α1 and one α2 chain. 











The  interaction  of  FN  and  collagen  was  first  demonstrated  in  1977  using denaturated collagen, which is called gelatin (Engvall and Ruoslahti 1977; Dessau, Sasse et  al.  1978;  Kleinman,  McGoodwin  et  al.  1978).  Balian  et  al.  showed  that  the  FN interaction‐domain  is  the  a  42kDa  fragment,  which  is  called  gelatin‐binding  domain (GBD) (Balian, Click et al. 1980). Furthermore, it was shown that this GBD bind collagen type I, II, III, IV and V in vitro (Shimizu, Minakuchi et al. 1997). Interaction studies of this domain have mostly been performed using denatured collagen (gelatin), which binds to the region with much higher affinity than native collagen. Important interactions of FN with collagen happen in collagen fibril  formation, where FN and integrin receptors are needed (Kadler, Hill et al. 2008). The interaction of FN with collagen is essential and of big  biological  relevance.  It  plays  a  fundamental  role  in  ECM  organisation  and  in fibrillogenesis. Furthermore, bacterial colonialisation of collagen is possible via binding to  FN.  The  interaction  is  also  implicated  in  the  removal  of  collagenous  debris  from damaged tissues. Figure  1.10  shows  a  model  of  the  ECM  and  the  interactions  between  FN  and collagen and integrin with the cytoplasm. Looking closer on how FN binds to collagen, an axial periodicity is noticed. This was suggested by cell culture studies (Dessau, Sasse et al.  1978).  The  interaction  is  only  possible,  when  specific  sequence  determinants  for binding  are  available  in  the  collagen  peptide.  This  pattern  consists  of  three  triplets. There, the first triplet has to have a hydrophobic residue. In the next two repeats strand‐breaking residues, like proline or 4‐hydroxyprolines, have to be absent. This basic 9‐mer pattern occurs 11 times in α1 and 17 times in α2 chain.  





 The main binding domain in FN for collagen is the 42 kDa proteolytic fragment, with the module composition 6FnI1FnII2FnII7FnI8FnI9FnI (GBD) (Balian, Click et al. 1980; Hynes 1985). The domain  is near  the N‐terminus of  each poly‐peptide  chain, which  is where  the  FnII  homologous  repeat  units  are  located  (Ingham,  Brew  et  al.  1988; Bocquier, Potts et al. 1999). The 2FnII and 8FnI modules possess N‐linked carbohydrate chains (Millard, Campbell et al. 2005).  The GBD can be divided  into  two  subfragments.  6FnI1FnII2FnII7FnI  termed  "the Quad" and 8FnI9FnI.  It  is already known that the 8‐9FnI  is responsible for tight binding, but the Quad also seems to play a role (Erat, Slatter et al. 2009). Figure 1.11 shows the main Collagen‐binding domains in FN. 
 
Figure 1.10: Model of the Extracellular Matrix and some of the most important interaction partnersof FN.  The shown interaction‐partners  are collagen, integrin α‐tail and integrin β‐tail (this figure was a kind gift of Prof. Iain Campbell) 





























9FnI  with  the  collagen  type  1  α1  chain  (collagenase‐site‐α1),  the  collagen  type  1 α1 (260‐site‐α1), collagen type 1 α2 chain (collagenase‐site‐α2) and the collagen type 1 α2 (260‐site‐α2). The work basically consists of four subtopics.   During the first part of the work the interaction between 8‐9FnI and the collagen type 1 α2 chain was characterised by NMR. We asked the following question: “How does 
8‐9FnI interact with α2 chain and how does this interaction differ from binding to the α1 chain (Erat, Slatter et al. 2009)?” We assume that the interaction of FN with collagenase‐site  is  tighter  than  with  the  260‐site‐α2  because  the  starting‐sequence  for  the collagenase‐site‐α2  is  more  hydrophobic  and  therefore  it  is  more  suitable  for interaction.  We  tried  to  verify  that  by  measuring  the  affinities  of  the  interactions between collagen type 1 collagenase‐site‐α2 and the collagen type 1 260‐site‐α2 with 8‐
9FnI.  As a second part of this thesis a defined interaction of 8‐9FnI with the 260‐site of collagen  type  1 α1  chain  is  reported.  This was  determined  using NMR  and  X‐ray. We tried to crystallise the interaction of 8‐9FnI and 260‐site‐α1 and the collagenase‐site‐α2. We obtained crystals  from  the  8‐9FnI  in  complex with collagen  type 1 260‐site‐α1 at a resolution  of  2.6Å.  The  structure  was  determined  by  using  the  method  molecular replacement.  Futhermore, another question of  interest arose, while  looking at  the  interaction of  collagen  type  1  collagenase‐site‐α1  with  8‐9FnI  (Erat,  Slatter  et  al.  2009)  –  the structure of  the  interaction complex  is shown  in Figure 2.2. We wanted  to know what the  binding  determinants were  for  the  interaction  of  collagen  type  1 α1  chain with  8‐
9FnI. 




 As a side project we tried to produce one triple‐helical  collagen  peptide  with  the  sequence  (GPP)6 GIAGQRGVVGLPGQRGERGFPGLP(GPP)6Y  by  bacterial expression.  This  sequence  is  the  collagen  type  1 collagenase‐site‐α1.  Instead  of  hydroxyprolines  it  has prolines.  The  crystal  structure  shows  that  the hydroxyproline side chains are not involved in a direct interaction  with  8‐9FnI  (Erat,  Slatter  et  al.  2009). According  to  that  there  won’t  be  any  binding‐difference  when  using  prolines  instead  of hydroxyprolines. Making triple helical collagen enzymatically, would have the advantage that it is cheaper and also might be quicker than buying the peptides. NMR could then be used  to  study  the  interaction  of  the  produced  collagen  type  1  peptide  with  GBD subfragments of FN.   So  basically  there  were  two  different  aims  of  this  diploma  thesis.  The  first concentrates  on  the  interaction  between  8‐9FnI  and  collagen  type  1. We  characterised three new binding sites and also  looked closer at another one (Figure 2.3), which was already studied by Erat et al.  (Erat, Slatter et al. 2009). The second aim points out  the possibility  to produce one triple helical peptide on our own. With this  thesis  I hope to gain a deeper insight into complex binding of FN with collagen type 1.              
 
Figure  2.2:  Crystal  structure of  the  8‐9FnI  in  complex  with collagen  type  1  collagenase‐site‐α1  (Erat,  Slatter  et  al. 2009) 




















  The protein sequences of  the FN fragments correspond to Homo sapiens (Taxid 9606).  The  8‐9FnI  protein  fragment was  produced  recombinantly  in  the methylotropic yeast  Pichia  pastoris  (Taxid 4922)  by  using  methanol induction  as  expression system.  P.  pastoris  produces post‐translational modifications  that  closely resemble  those  of  higher eukaryotes  compared  to 
Escherichia  coli.  Another advantage of  the used  system is  its  robustness.  The  cells  can  be  easily  grown  in  fermentors  at  high  cell  density  on defined  media  making  isotopic  protein  labelling  easy  (Bright,  Pickford  et  al.  2000). Figure  3.1  shows  the methanol  utilisation pathway of P.  pastoris.  The Alcohol  oxidase (AOX) gene has a strong inducible promoter and allows P. pastoris to use methanol as a carbon and energy source (Sreekrishna, Brankamp et al. 1997). The same promoter can be used for the recombinant protein, thus protein expression is induced by addition of methanol (Cregg, Madden et al. 1989; Cereghino and Cregg 2000). 
 
Figure  3.1:  Methanol  Utilization  Pathway.  The  enzymes are  shown  in  black:  Alcohol  oxidase  (AOX),  format Dehydrogensae (FMD), Dihydroxyacetone synthase (DAS) http://www.biotechresources.com/hansenula_yield.html  






P. pastoris successfully produces protein in shake flasks. However the cell density, thus the amount of protein produced is limited. Limiting factors include low oxygen into the culture, acidification of the growth media by catabolites and sub‐optimal methanol levels, which can poison the culture. A  fermentor allows optimizing of  these  factors as well as continuous monitoring and adjusting of the culture’s growth conditions. Base can be added to ensure that the culture does not acidify, and increasing the agitation speed or addition of oxygen maintains adequate oxygenation of the culture. The methanol used to  induce  protein  production  can  also  be  added  at  an  optimal  rate  to  ensure  that  the overall oxygen level does not drop too low and that the overall methanol concentration in the fermentor does not become too high and thus poison the culture.  The  major  disadvantage  of  fermenting  P.  pastoris  is  the  increase  of  proteases, which occurs  in  the  growth media  as  biomass  increases  and  cell  death/lysis  happens. Temperature  limiting  conditions  reduce  cell  death  and  susceptibility  to  methanol toxicity,  slow  proteolytic  enzymes  and  possibly  increase  the  AOX1  promotor  activity. Low temperatures may also  increase  the stability of  the recombinant protein and also decrease  its  susceptibility  to  proteolysis.  Therefore  fermentation  was  done  at  25°C (Chung 2000). 
3.1.3. Materials and Methods 
P. pastoris fermentation The  fermentation  was  carried  out  in  a  1l  fermentor,  following  the  detailed protocol of Uli Schwarz‐Linek, 2003 (Schwarz‐Linek, Werner et al. 2003).   




 Protein recovery and purification A  large SP‐Sepharose cation exchange column (50ml bed volume) was used  for the  first  purification  step.  Protein  rich  fractions  were  pooled  and  cut  with  EndoH overnight afterwards. EndoH is a recombinant fusion protein of Endoglycosidase H and maltose  binding  protein.  Its  main  function  is  cleaving  the  chitobiose  core  of  high mannose and some hybrid oligosaccharides from N‐linked glycoproteins. The last step of purification  is high‐pressure  liquid chromatography  (HPLC) using a  reverse phase C4‐column. The sample then was freeze‐dried.  
 
 






The  main  used  techniques  in  my  theses  are  Nuclear  Magnetic  Resonance  and Crystallography. I would like to discuss both shortly. 
3.2.1 NMR as technique 
The theory of NMR technique is well described in the books Understanding NMR 





Figure  3.2:  Schematic  representation  of  the most  important  steps  of  a  2D  NMR  experiment: Preparation – evolution (t1) – mixing (τm) – detection (t2) (adapted from a lecture of Prof. Robert Konrat, University of Vienna) 




 It  is  possible  to  divide  a  2D  NMR  pulse  sequence  into  the  four  blocks.  This  is described in Figure 3.2: Preparation – evolution (t1) – mixing (τm) – detection (t2).  Prior  to  the  preparation  period  the  sample  is  at  a  thermal  and  a  magnetic equilibrium. At the end of this period, transverse magnetization has been induced by the application of a 90° radiofrequency (RF) pulse. The next block  is  the evolution period. During  this  time  uninterrupted  free  precession  for  a  time  t1  is  allowed.  There,  the detected magnetisation produces signals whose frequencies correspond to the F1 (D2) dimension of the resulting 2D experiment. The evolution time t1 is increased in discrete steps  up  to  a  maximum  value,  called  t1,max.  A  mixing  period  follows  during  which magnetisation  from  one  spin  to  another  is  transferred.  This  period  initiates  the correlation between  the  two dimensions of  a 2D NMR spectrum. The mixing period  is terminated by another 90° RF pulse, then the transverse magnetisation is detected as a free‐induction decay (FID). 
3.2.1.2. Heteronuclear single­quantum correlation (HSQC)­ experiment 
The heteronuclear single‐quantum correlation (HSQC) experiment correlates the chemical  shifts of  the amide proton and  15N nitrogen within particular  labelled amino acid  residues.  In  Figure  3.3  shows  a  schematic  overview  of  a  typical  HSCQ  pulse sequence.   





 The HSQC experiment provides information about nearly all amino acid residues. One  exception  is  proline,  because  it  does  not  have  a  backbone  amide  proton.  The changes in the chemical shift of a particular peaks in the spectrum reflect the changes in the  shielding,  which  is  experienced  by  the  observed  nuclei.  These  changes  represent then  alterations  in  the  protein’s  structure,  which  are  due  to  binding.  The  HSQC‐experiment  can  be  used  to  obtain  information  on  the  changes  of  chemical  shifts  that occur while an interaction of two proteins. HSCQ titration studies are used to study the binding characteristics of the given proteins. This technique has been used to study the interaction  between  FN  and specific collagen sites.        
 
Figure  3.3:  Pulse  sequence  for  a  Heteronuclear  Single  Quantum  Coherence  (HSQC) experiment (adopted from a lecture by Professor Robert Konrat, University of Vienna). The results 2D spectrum has one axis for 1H and another one for a heteronucleus. The spectrum consists out of peaks for each proton attached to the heteronucleus. 
 
Figure 3.4: Overview of how change in chemical environment leads to change in chemical shifts. 






The theory about crystallography  is well described  in  the  two books “Outline of 
Crystallography  for  Biologists”  (D.  Blow,  2002)  and  in  the  book  “Crystallography made 
crystal  clear  –  a  guide  for  Users  of  Macromolecular  Models”  (G.  Rhodes,  2006).  All information for the “crystallography part” was taken out of these two books. 
3.2.2.1 Introduction to crystallography 










For the crystallisation of proteins and protein complexes the availability of pure and monodisperse material is important. Through technical modifications the screening procedures  are  easier  than  in  former  days  and moreover  it  is  possible  to  reduce  the amount of protein necessary to identify crystallisation conditions and obtain diffraction quality crystals. The University of Oxford owns a TECAN crystallisation robot, which can be used for several screens of various proteins for new crystallisation. The most popular method is vapour diffusion. For that a small amount of protein (typically 0.1‐1µl at 10‐25mg/ml)  is mixed with an  identical volume of mother  liquor,  including a precipitant, and equilibrated in a sealed environment over the same mother liquor. The water in the protein drop diffuses until equilibration with the precipitant concentration in the well is reached, so consequently a concentration of the protein in the drop is achieved until the supersaturated state  is  reached. The rate of diffusion  is determined by  the precipitant concentration,  and  will  result  in  a  number  of  phenomena  in  the  protein  drop.  These phenomena vary from aggregation to solubility and hopefully crystals. Sitting or hanging drops can be used with vapour diffusion. The difference between these two methods is shown in Figure 3.6.        
 
Figure 3.6: Difference between sitting and hanging drops In both methods a few microliters of protein solution are mixed with  an  equale  amount    of  reservoir  solution,  containing  the precipitants. Sitting  drops  method:  A  drop  of  this  mixture  is  then  put  on  a protein reservoir, which is close to the reservoir solution Hanging  drop  method:  A  drop  of  the  mixture,  containing  the protein and precipitant,    is put on a glass slide which covers the reservoir.   




 Figure  3.7  give  a  schematic  overview  of  the  main  steps  in  protein  structure determination by crystallography.  
 
 
Figure  3.7:  Schematic  diagram  of  the  main  steps  in  protein  structure determination After the pure protein crystallises, the charcterisation of the crystal strucutre is the  next  step  by  using  the  following  methods:  data  reduction  and  scalling, phasing,  electron  density mac  calculation, model  building  and  refinement.  The last step is the validation and analsis of the structure. 






X‐rays are high‐energy electromagnetic waves with a wavelength of 0.1 to 100Å. Protein crystallography uses hard x‐rays (0.1‐2Å). Scattering from biological specimens is weak and mainly comes from carbon, oxygen, nitrogen, sulfur and phosphorus atoms. In  addition  to  their  weak  diffraction,  proteins  exposed  to  X‐rays  experience  damage from ionising radiation. The brightest and most useful X‐ray sources are synchrotrons. They have very high luminosity, which allows faster data collection. It is also convenient to tune the wavelength of the radiation, which is useful for multi‐wavelength anomalous dispersion  (MAD)  phasing.  Data  collection  of our  used  crystal  in  this  diploma  thesis  was carried out at  the ESRF synchrotron source  in Grenoble, France.  The  synchrotron  at  the  ESRF  (Figure 3.8) is 844m in circumference. In this electrons circulate  at  a  speed  approaching  the  speed  of light.  The  electrons  are  first  accelerated  in  a linear accelerator (linac) up  to  the energies of 200 MeV. They are then injected into a booster synchrotron  and  accelerated  to  6  GeV  before injection  into  the  main  storage  ring.  A  huge  advantages  of  a  synchrotron  as  a  X‐ray source  is  high  intensity  and  the  available  brightness.  Especially  brightness  is  a  big advantage  for  small  and weakly  diffracting  crystals,  and  crystals  that  have  very  large unit  cells.  Furthermore,  data  collection  is  very  rapid.  Each  crystal  is  illuminated with much  higher  number  of  photons  per  second  than  at  a  rotating  anode  diffractometer. 
Figure  3.8:  The  synchrotron  at  the ESRF in Grenoble, Switzlerand (http://www.esrf.eu) 




 Secondary radiation damage can be reduced, by collecting data from crystals at super‐cooled  to  100K  in  a  stream  of  gaseous  liquid  nitrogen.  The  high  solvent  content  in protein crystals can result in ice‐formation that obstructs protein diffraction. Therefore it  needs  to  be  minimized.  This  can  be  done  by  rapid  crystal  incubation  in  a  cryo‐protectant, which prevents formation of crystalline ice from the solvent. The protectant is usually glycerol. The crystal  is transferred using a nylon loop held in a steel pin and secured  to  the goniostat by means of a magnetic base. While  freezing,  the presence of cryo‐protectant slows down ice crystal formation and vitreous ice is then formed. After collection of the data, the data is processed. 
3.2.2.4 Data processing   
  In the summation process, the pixels within a  defined  box  around  the  reflection  are  added together.  Through  the  neighbouring  pixels  the background  is  calculated  and  subtracted.  The profile  fitting  method  fits  an  empirically‐derived reflection  profile  to  the  data  and  integrates  the reflection.  This  process  consists  out  of  two  steps. During  the  first  one  a  standard  profile  is determined, independently of the intensity of the reflection. Scaling and integrating the profiles  to  the  recorded  data  follow  the  first  step.  Observed  profiles  vary  over  the detector area, thus the detector is split into several standard profiles. Averaging the fully recorded  reflections  above  certain  intensity  from  five  to  ten  consecutive  images  then generates  the  standard  profile.  When  crystals  have  a  high  mosaicity,  the  images  are unlikely  to  generate  fully  recorded  reflection,  as  the  oscillation  angle  during  data 
   
Figure 3.9: A diffraction pattern  of  the  2.6  Å  crysatl  of  the interaction  between  8‐9FnI  and collagen type1 260‐site‐α1  




 collection  will  be  reduced  to  avoid  overlaps.  The  partially  recorded  reflections  from consecutive  images will be added and considered as  fully  recorded reflections used  to contribute  to  the  standard  profiles.  At  the  end  the  fitted  profiles  are  integrated  by summing the background corrected pixel values. Finally a file containing all reflections with  their  Miller  indices  and  associated  I  and  σI  values  are  generated  from  the integration. 
3.2.2.4.1. Scaling Through  scaling  an  assessment  of  the  collected  data  quality  can  be  made. Comparison of recorded observations and their symmetry‐related reflection  is used to determine the scale factors relating them. Multiple observations for each reflection are then scaled and merged  into an average  intensity. The program SCALA (CCP4)  is used for  this  (Potterton,  McNicholas  et  al.  2002).  The  Rmerge  value  reflects  the  remaining errors  after  scaling.  With  increasing  multiplicity  due  to  crystal  symmetry  Rmerge  will inevitably  increase,  but  data  redundancy  increase  data  quality  as  each  reflection  is recorded several times.  
3.2.2.4.2. Phasing Once  the  collected  data  has  been  reduced  to  one  singe  file  containing  all  the structure factor amplitudes for the Miller Indices in the asymmetric unit, phases for the reflection  can  be  determined.  Phases  can  be  obtained  experimentally  using  several direct methods like Multi‐wavelength/single anomalous dispersion (MAD, SAD).  A second method is molecular replacement. In this step, phases are derived from an  initial  structural model.  It  requires  a  previously  solved  structure,  which  has  to  be closely  related  to  the  protein  of  interest.  In  our model  the  data  from PDB  entry  3EJH (Erat,  Slatter  et  al.  2009) was used  for molecular  replacement.  In  this  process  phases 




 from  the  known model  can  be  used  to  calculate  an  image  of  the  target  molecules  in combination with the calculated structure factors. The model replacement program then calculates  the orientation and position of  the  target molecule  in  the unit  cell  from  the model‐derived  phases.  For  this  purpose,  the  orientation  and  position  of  the  target molecules in the unit cell must be determined through a search. Searching in molecular replacement  is  separated  into  two  steps.  The  first  one  is  called  “rotation  function”. During this process the orientation of the target molecule is determined. In the second step  the  position  of  the  target  molecule  is  established,  which  is  called  “translation function”. Key  to  the molecular  replacement  strategy  is  the Patterson  function. This  is basically an equivalent to a Fourier summation of all the intensities with the phase equal to  zero,  but  it  also  represents  a  vector  map.  The  Patterson  function  is  performed  in Patterson space with a vector u at a given position (u, v, w). 
 
and   For this step, the “translation function”, we used the program PHASER (Adams, Grosse‐Kunstleve et al. 2002). 
3.2.2.4.3. R factors Two  R  factor  measurements  are  indicators  of  the  quality  of  the  model.  They quantify  the  discrepancy  between  the  calculated  structure  factor  amplitudes  from  the model and the empirical observed structure factor amplitudes. The agreement between the calculated model and the observed data is described by the R‐factor: 







Once  phases  have  been  assigned  to  reflections,  it  is  possible  to  calculate  an electron density map from our experimental data for the protein structure. The quality of  the  electron  density  depends  on  the  phase  errors.  Phase  improvement  by  model building  into  the  electron  density  and  refinement  becomes  an  iterative  process.  The quality of the map also relies on the resolution. A high‐resolution map will offer greater details than a low resolution one. The program Coot was used to fit a structural model to our electron density map (Emsley and Cowtan 2004). Two types of maps were used with different weightings highlighting different aspects of  the experimental data: 2FOFCWT and  FOFCWT.  The  difference  density  map  FOFCWT  highlights  features,  which  are presented in the experimental data and do not give a satisfactory record of the model. It is  the  first evidence  for binding of peptides  in  this  thesis. The atoms are placed  in  the difference  electron  density  map  2FOFCWT.  This  is  the  sum  of  the  observed  and  the difference density maps and is used for rebuilding.  Finally  when  a  three‐dimensional  structure  of  the  protein  with  good stereochemistry is built and improved to obtain good agreement between the model and the experimental data, refinement is monitored using two values the Rwork and the Rfree factor. Model‐building is a labour intensive process. The model is fitted into the electron 




 density calculated from the best phases available by adjusting the x, y and z coordinates of  the  model.  As  the  quality  of  the  phases  increases,  the  maps  should  become  more interpretable.  The  three‐dimensional  structure of  the protein  is  built  in manually  into the  interpretable  electron  density  using.   When  there  is  too  little  electron  density  in some parts it is not possible build this part of the model. The program PHENIX GUI was used  for  deriving  density  maps  from  our  structure  factors  and  the  structural  model (Adams, Grosse‐Kunstleve et al. 2002).    







For the titrations concerning the interaction of 8‐9FnI with the collagen type 1 α2 chain all conditions were the same. The  used  buffer  was  150mM NaCl  and  20mM NaKPi  (pH7.2).  5%  D2O  and  0.5%  DSS were added to each sample to a final volume of 160µl. All HSQC‐titration were acquired on a 500MHz Bruker spectrometer. 
3.3.1. Sample preparation 
NMR samples were  typically  composed of  a  final  concentration of  0.1mM  for  8‐
9FnI  (15N  enriched)  and  varying  concentration  (0‐2mM)  of  the  different  collagen peptides. 
3.3.2. Binding studies of the interaction of 8­9FnI with collagen type 1 
260­site­α2 (G254­D277) and its core­sequence (G260­D268) 
A  series  of many  eight different  concentrations of  the  collagen  type 1 α2 G254‐‐ D277  was  done.  It  was  started  by  0.0mM  and went  until  1mM.  For  the  core‐sequence seven different concentrations between 0.0mM and 2mM were done Sequence of 8‐9FnI: (D516‐S608):   
   
DQCIVDDITY NVQDTFHKKH EEGHMLNCTC  
FGQGRGRWKC DPVDQCQDSE TGTFYQIGDS  
WEKYVHGVRY QCYCYGRGIG EWHCQPLQTY PSS 





   GLOGFKGIR (29.5mM).  The HSQC experiment with collagen type 1 260‐site‐α2 was carried out at 298K (25°C), for the core sequence the temperature was at 310K (37°C).    










NMR samples were  typically  composed of  a  final  concentration of  0.1mM  for  8‐
9FnI and varying concentration between 0mM and 1mM of the collagen type 1 260‐site‐
α1 peptide. Sequence of 8‐9FnI was the same as in paragraph 3.3.2: Sequence of the collagen type 1 260‐site‐α1 (G254‐Y277):       GLOGTAGLOGMKGHRGFSGLDGY (c = 17.8 mM) GLOGMKGHR is the main binding sequence in collagen type 1 260‐site‐α1 for 8‐9FnI. 
3.4.2. Crystallisation  of  the  8­9FnI  in  complex  with  collagen  type  1 
260­site­α1  
3.4.2.1. Crystal growth 
  Crystals  were  grown  under  0.1M  Hepes  (pH  7.5)  and  4.3M  NaCl.  The  vapour diffusion method was used to form crystals from sitting drops dispensed by a mosquito Crystal robot (TTP LabTech). The drops consisted of 100nl of an equimolare mixture of 




 protein  (15µg/µl)  and  peptide,  and  mother  liquor.  Crystals for  these studies  formed after  incubation  for  three weeks at 293.1K  (20°C).  The  crystals  then  were  cryo‐protected  by transfer to a reservoir solution supplemented by 5% vol/vol glycerol and flash frozen.  
3.4.2.2. Data collection and processing 
A  dataset  was  collected  at  the  X‐ray  diffraction  beam  line  ID29  at  European Synchrotron  Radiation  Facility  (ESRF,  Grenoble,  France).  The  detector  was  an  ADSC Q315R CCD, which has an active area of 315 x 315mm2 and typicall readout time of 1s in unbinned mode  or  0.3s  in  binned mode.    The  silicon monochromator  had  as  optics  a cylindrical  glazing  incidence  mirror.  The  dataset  was  processed  and  merged  using MOSFLM (intensity‐integration software (Powell 1999) and SCALA (CCP4 – data scaling software).  The  structure  of  8‐9FnI  together with  the  Collagen  residues  G254  –  Y277 was determined  by molecular  replacement  using  the  program PHASER  (McCoy  2007)  and  the PDB entry 3EJH (Erat, Slatter et al. 2009) as starting model. Chain A and a part of chain E were used from this PDB entry.  
3.4.2.3. Structure determination and refinement 
The  8‐9FnI  collagen  type  1  260‐site  α1  (G254  –  Y277)  model  underwent  several cycles  of  rigid  body  refinement  using  REFMAC5  (Vagin,  Steiner  et  al.  2004). Subsequencly, rounds of restrained refinement using PHENIX refined the structure.  The program  PHENIX  GUI  (Adams,  Grosse‐Kunstleve  et  al.  2002)  was  used  to  calculate electron density maps by initial models. For refinement non‐crystallographic symmetry restraints between parts of chain A and B (protein) and E and F (peptide) of the complex 
 
Figure 3.10:  Crystal  of 8‐9FnI  in  interaction with collagen type 1 α1  




 and TLS refinement with one group per FnI domain or peptide polypeptide chain were used. The model was built manually using the program Coot (Emsley and Cowtan 2004). Water positions were manually identified from the electron density maps.   In one copy (chain F) it was possible to built peptide residues G254, L255 and G260 – L273,  residues O256 – A259 and D274 – Y277 are missing.  In  the other  copy  (chain E) only residues G260 – F270 could be built, and residues G254 – A259 and S271 – Y277 are missing. 






















A series of 5 different  concentrations of  the collagen peptide was done  for  that experiment.  It was  started by 0.0mM and went until  3.0mM.  Sequence of  the  collagen type 1 collagenase‐site‐α1 (SV‐mutation):  
GQRGSVGLOGQRGERGFOGLOGY  (c=18.46mM) The temperature of the experiment was 298 K (25°C). This experiment was carried out on an Oxford Instrument 950MHz NMR system.  
















 Whether  subcloned  from  another  vector  or  amplified  by  PCR,  the  insert  must have  ends  that  are  compatible  with  the  linearized  vector  ends.  Using  two  different restriction enzymes will allow for directional cloning of the insert into the vector. Insert  The insert was synthesised by using PCR methods, described later in this chapter. The sequence is given below.  Protein sequence: LEVLFQ(GPP)6GIAGQRGVVGLPGQRGERGFPGLP(GPP)6 Y DNA‐ Sequence (224bp):  
GGG ATG CAT ATG CTT GAA GTT CTT TTT CAA GGT CCT CCT GGC CCT CCA 
GGA CCG CCG GGT CCA CCT GGC CCA CCG GGT CCA CCT GGG ATT GCT GGT 
CAA CGT GGT GTT GTT GGT CTT CCT GGT CAA CGT GGT GAA CGT GGT TTT 
CCT GGT CTT CCT GGC CCA CCA GGT CCT CCA GGT CCA CCG GGT CCA CCA 
GGA CCG CCC GGA CCG CC TTA TTA ACT CGA GGG  The whole construct has a molecular weight of 5554.3 Da. 
3.6.2. Methods 
3.6.2.1. Construction of the insert by PCR techniques 
The  DNA‐Polymerase  Vent  was  used.  Vent  is  a  high‐fidelity  thermophilic  DNA polymerase,  which  as  an  integral  3'→5'  proofreading  exo‐nuclease  activity.  The synthesis was  started  as  it  is  shown  in  Figure  3.12.  The  PCR‐reaction was  started  by amplifying  the  middle  part  of  the  peptide,  which  is  called  T1.  By  every  other  PCR‐reaction a new piece of the peptide was added.  





   Program for PCR reaction:  4’        @95°C     30’’   @95°C     30’’   @50°C  2’30’’        @72°C ‐25 cycles 7’       @72°C Every  PCR  product  was  further  purified  by  extraction  from  agarose  gel  after electrophoresis.  
3.6.2.2. Vector amplification 









 Digest‐reactions were incubated for 2h at 37°C.   PCR‐reaction  40µl Buffer BamHI    5µl Enzyme XhoI    1 µl Enzyme BamHI    1µl H2O    3µl Total  50µl  To  inhibit  re‐ligation,  the  vector  was  treated  with  NEB  Antarctic  Phosphatase  for  1h 30min at 37°C.   
 The digested  inserts and digested, dephosphorylated vectors were gel‐purified using a Gel purification kit (Qiagen). 
3.6.2.4. Ligation 
The construct was cloned into the BamHI and XhoI sites of the vector pGEX‐6P‐2 (GE Healthcare). T4­DNA­Ligase  from New England Biolabs was  used  for  ligation.  The dilution of  vector  and  insert were  tried based on  calculation of  the  correct  amount of insert in ratio to the vector (shown below)  
  
   
vector  40µl Antarctic Phosphatase  5µl Buffer  1µl H2O  4µl Total  50µl 




   Ligation  Control 1  Control 2 Vector  1 µl  1 µl   1 µl  Insert  15 µl  0 µl  0µl 10x Buffer  2 µl  1µl  1 µl Ligase  1 µl  1 µl  0 µl H2O  1 µl  6 µl  7 µl Total  20µl  10µl  10µl  The reaction was incubated over night at 191.15K (18°C). 
3.6.2.5. Analysis of clones by Colony PCR 




We  used  E.coli  as  expression  system.  E.coli  expression  systems  are  well established and there are good sources of protocols and media recipes. Given the codon usage differences between humans and E.coli the constructs are transformed routinely into the strain BL21‐CodonPlus (DE3)‐RIPL (Stratagene) for protein production. These high‐level protein expression cells contain a plasmid encoding extra copies of the argU (AGA,  AGG),  ileY  (AUA),  and  leuW  (CUA)  as well  as  the  proL  (CCC)  tRNA  genes.  This strain rescues expression of heterologous proteins from organisms that have either AT‐ or GC‐rich genomes. To increase expression yields it is best only to select for the Codon plus plasmid with Chloramphenicol  and Carbenicillin  in  the overnight  starter  cultures and express the protein in the absence of Chloramphenicol. 






A  colony  was  incubated  in  20ml  LBCabenicellin  +  Chloramphenicol  at  298.1K  (25°C) over  night.  In  the  morning  the  overnight  culture  was  transferred  into  1l  M9‐(15N)‐media  and  incubated  at  25°C  for  about  4h,  until  an  O.D:  of  0.5  was  reached.  The overexpression  started  by  adding  IPTG,  to  a  total  concentration  of  0.35mM.  After  5 hours  the  cells were  spun  down  at  8000rpm  for  15mins.  The  pellet was  dissolved  in 40ml 1xPBS‐buffer. To  lyse  the  cells  they were  thaw and  frozen  in  liquid nitrogen  for three  times.  MgSo4  to  a  final  concentration  of  20mM  and  DNaseI  were  added  and incubated for 5min at room temperature. Triton X‐100 (to a final concentration of 1%) was  then  added  to  the  obtained  cell  lysate  in  order  to  prevent  aggregation  of  the overexpressed protein. The lysate was again incubated for 5min on ice. To  go  on  to  the  purification  steps  the  cell  lysate was  first  spin  down  at  13000rpm at 277.1K (4°C) for 30mins. The supernatant was used for purification. 
3.6.2.9. Purification steps 
1st purification step The  first  purification  step  of  the  target  peptide  was  done  by  an  affinity‐chromatography‐column with glutathione 4B Sepharose. Thus, non GST‐tagged proteins were removed as they would have no affinity for the column (Harper S. and W. 2008).   





2nd purification step The second purification step was done by using 3c protease. With the help of that very  specific  rhinovirus  thiol  protease  a  specific  amino  acid  sequence  was  cleaved. Proteolysis  cleaved  the  GST  affinity  fusion  domain.  The  protease  is  active  at  low temperatures,  thus  it was possible  to do  the proteolysis at 4°C over night (Cordingley, LaFemina et al. 1990; Walker, Leong et al. 1994). 
3rd purification step The  sample  pH was  adjusted  to  4.9  to  precipitate  GST  out  of  solution  and  the sample was heated  to 358.1K  (85°C)  for 10min. The collagen peptide  is  soluble under these conditions, thus it will not be removed. 
4th purification step The  sample was  further  purified  by  gel  filtration  chromatography.  The  column HiLoad 26/60 Superdex 75 was used. Figure 3.13 shows the technical specifications for that column: 









Analysis of  the  sample was done by  circular dichroism  (CD) and MASSPEC. We used CD, because of the unique signal of the triple‐helical state.     
Fractionation range (Mr)     ‐ Globular proteins     ‐ Dextrans  










 In  the  4th  chapter  “Results”  of  my  diploma  thesis,  I  first  like  to  discuss  the production  of  8‐9FnI  and  its  purification  in  P.  pastoris;  then  turning  to  the  bindings studies  in collagen  type 1 α2 chain. The characterisation was done by using NMR. We wanted  to  find  out  if  there  is  any  interaction  and  if  so,  where  the  differences  lie  in binding  between  8‐9FnI  and  collagen  type  1  α1  chain  (Erat,  Slatter  et  al.  2009).  We verified  the  binding  between  8‐9FnI  and  collagen  type  1  collagenase‐site‐α2,  which  is presented by Erat et al. (Erat, Slatter et al. 2009). Our focus lies therefore on the binding between 8‐9FnI and collagen type 1 260‐site‐α2.  As  another  subtopic  I  then  discuss  the  interaction  between  8‐9FnI  and  collagen type 1 260‐site‐α1. There it was possible to characterise this binding by using NMR and crystallography.  I  will  discuss  in  particular  the  crystal  complex  of  these  two  binding components. We obtained crystals at 2.6 Å in space group P3121 with two molecules of 8‐
9FnI and two collagen peptides per asymmetric unit. In the third subchapter,  I will discuss the binding determinants  for high affinity binding  between  8‐9FnI  and  collagen  type  1  collagenase‐site‐α1.  Michèle  Erat  already characterised  this  site  (Erat,  Slatter  et  al.  2009).  Until  now  it  is  still  unclear  what  is responsible for the high affinity.  After discussing all possible binding sites between the 8‐9FnI and collagen type 1, the  last point  to make  is whether  it  is possible  to produce  these collagen triple helical peptides by us. 
 
 






The  8‐9FnI  was  produced  by  fermentation  from  P.  pastoris.  After  successful fermentation and protein  recovery, purification using a SP‐Sepharose‐Cation exchange column was started.   
Figure 4.1 shows the elution chromatogram of 8‐9FnI from a SP‐Sepharose‐Cation exchange  column.  This  purification  step  worked  well  and  the  spectrum  looks  as expected.  A  “shoulder”  can  be  seen  at  the  fractions  5‐9  in  the  spectrum. Michèle  Erat purified  the  two  fractions  separately  beforehand.  She  could  not  find  any  significant difference.  Therefore  we  assumed  that  the  whole  fraction  is  8‐9FnI,  so  we  pooled  the fractions  5‐20 with  the  highest  protein‐concentration  together.  After  purification,  the sample was  incubated over night with EndoH. The next purification step was done by HPLC.   
 
Figure 4.1: Purification of 8‐9FnI by using a Ion‐Exchange Column For  this  purification  step  12.3ml  of  our  sample was  loaded  onto  the  column.  The sample came out after 280ml. blue: Protein absorbance, brown: salt concentration 





 Figure 4.2 shows the chromatogram of HPLC purification. The spectrum looks as expected. Again  the  richest  protein  fractions were pooled  and  freeze‐dried. The  8‐9FnI was used for further interaction studies with collagen type 1 peptides. 
 
Figure 4.2:  Purification by HPLC  (high performance  liquid  chromatography‐ FatBoy‐column)  The  sample  came  out  after  19min.  The  sample  then  was collected and freeze‐dried. 





4.2. Binding  studies  of  the  8­9FnI  in  interaction  with  collagen 
type 1 α2  
First we looked at the interaction between 8‐9FnI and collagen type 1 α2 chain by using NMR. We wanted to know it there is any interaction and if so, how it differs from binding  between  8‐9FnI  and  collagen  type  1  α1  chain  (Erat,  Slatter  et  al.  2009).  All samples were prepared as described  in  the chapter  “Materials and Methods”. Here we characterise  the  interaction  between  8‐9FnI  and  collagen  type  1  260‐site‐α2.  We assumed  just  very  little  binding  here,  because  the  starting‐sequence  is  not  as hydrophobic as the one from the collagenase‐site. We tried to verify the hypothesis by using affinity measurement.  
4.2.2. Binding studies of the interaction of 8­9FnI with collagen type 1 
260­site­α2 (G254­D277) and its core­sequence 
Starting by  looking at  the  interaction of  8‐9FnI with  collagen  type 1 260‐site‐α2 (G254‐D277) a series of many eight different concentrations of the collagen type 1 peptide was done. It was started by 0.0mM and went until 1mM. The titration is fast on the NMR timescale, thus resonance perturbations can be used to determine a proper and reliable Kd‐value. Assuming a 1:1 bimolecular association model, a Kd‐value of 1.38 ± 0.17 mM for interaction between the 8‐9FnI and collagen type 1 260‐site‐α2 was calculated.   









α2  (G254‐D277): A Kd‐value of 1.38 ±  0.17 mM was determinded, which means  that  the binding is very weak. Blue: 0.0mM collagen peptide; Red: 1mM collagen peptide 
 
Figure 4.4: Looking closer at the peaks, it is possible to see how the peaks shift. Blue: 0.0mM collagen peptide; red: 1mM collagen peptide  




   By examining the 8‐9FnI structure (Erat, Slatter et al. 2009), it is easy to see, which amino  acids  are  influenced  by  the binding  (labelled  blue  in  Figure  4.5). Peaks  are  shifted  over  the  whole structure,  which  means  that  the electronic  surroundings  of  the  specific nuclei change. It seems that this is due to changes  in  the  protein  or  due  to secondary effects.  For  a  deeper  insight  into  the actual  binding‐site  of  “260‐site”  with  8‐
9FnI, the core sequence was tested alone. The sequence  is GLOGFKGIR (29.5mM). For  the  core‐sequence  seven  different concentrations  between  0.0mM  and 2mM  were  done.  The  Kd‐value  was calculated to be 2.27 ± 0.44 mM. 
 
Figure 4.5: Moving peaks shown on the 8‐9FnI model. The moving peaks shift over the whole strucutre,  which  means  that  the  electronic surrounding of the specific nuclei change. 





  According to this titration there are nearly no perturbed resonances, which is an indication  that  the  residues  of  this  core‐sequence  contribute  much  less  to  binding compared to residues of the collagenase α1 core sequence (Erat, Slatter et al. 2009)    
  Figure 4.6: NMR HSQC spectrum of the titration 8‐9FnI with collagen type 1 260‐site‐α2 (core sequence): A Kd‐value of 2.27 ± 0.44 mM was obtain. There is hardly no binding to see. Red: 0.0 collagen peptide; Blue: 2mM collagen peptide. 





















a)                b) 
  
Figure 4.8: a) Zoom in, where you can see that a fast exchange is happening b) shift differences between 0.0mM and 1mM of the collagen type 1 α1 ‐260‐site of I522 






α1  are  shown  in  Figure 4.10.  They  are Q517, D521, N527,  T530,  F531,  K532, H534,  E535, H538, N542, G547, Q550, W552, C555, C561, E565, Y570, E577, K578, V582, R583 and Y587. These residues are coloured in blue. 
    Figure  4.10:  Shifting  peaks  on  the  8‐9FnI.  The  moving  peaks  shift  over  the  whole strucutre, which means that the electronic surrounding of the specific nuclei change. 
 
Figure 4.9: Origin data  for  the  8‐9FnI  in  interaction with collagen type1 260‐site‐α1 







After  detecting  binding  between  8‐9FnI  and  collagen  type  1  260‐site‐α1  it  was attempted  to  crystallise  that  complex.  This  was  successful  under  the  following conditions:  the buffer was 0.1M Hepes (pH 7.5) and 4.3M NaCl. The first crystals grew after four days at 293K (20°C), by using vapour diffusion method. A picture is shown in chapter 3.4.2.1, Figure 3.10. The  structure  of  8‐9FnI  together  with  the  Collagen  residues  G254  –  Y277  was determined by molecular replacement. The crystallographic dataset statistics and model reﬁnement are given in Figure 4.11. They describe the most important parameters of the crystal. Crucial parameters are  for example  the  two R‐values, Rfree  and Rwork. They are indicators of the quality of the model. The closer the two values are together the better is  the  model’s  quality.  Another  important  parameter  is  the  space  group.  This  gives significant information about the crystal’s symmetry.    






Cell collection   Space group  P3121 Cell dimension (Å)  a = b = 56.70 c = 152.661 
α = β = 90 
γ = 120 Maximal resolution (Å)  46.676 – 2.558 Wavelength (Å)  0.9762 Unique reflections, completeness  16804 Rmerge (%)  0.074 Mean I /σ (I)  14.500 Completeness (%)  99.8 Rsym1 (%)  0.074 Reﬁnement statistics    Resolution (Å)  46.65 – 2.6 Unique reflection  16796 Free set  1242 (7.39%) Rwork  0.223 Rfree  0.271 Overall mean B values (Å2)  57.63 Number  of  amino  acid  residues  per  asymmetric  unit (protein and ligand)  227 Number of water molecules  43 Matthews coefﬁcient  2.68 RMSD from ideal values   Bonds, Å/angles,  0.003 / 0.683 Estimated overall coordinate error based on maximum likelihood, Å  0.990 Estimated phase error based on maximum likelihood,  0 MIN (FOBS/σ‐FOBS)  0.190 Ramachandran plot statistics    Residues in favored regions (%)  94.74 Residues in allowed regions (%)  5.26 Residues in disallowed regions (%)  0  
Figure 4.11:  X‐ray data  collection  and  refinement  statistics  for  8‐9FnI  collagen  type 1 260‐site‐α1 (G254 – Y277) complex 






  Gopalasamudram  Narayana Ramachandran  developed  the  Ramachandran plot.  It  is a way  to visualize dihedral angles Φ (phi)  and  Ψ  (psi).  The  Ramachandran  plot shows  the  allowed  combinations  of  the conformational  angles  Φ  (phi)  and  Ψ  (psi). Since Φ  (phi) and Ψ  (psi) refer  to rotations of collisions  either  between  atoms  in  different peptide groups or between a peptide unit and the side chain attached to Cα  (Ramachandran, Ramakrishnan et al. 1963). The coloured areas show sterically allowed regions. They are split  into three important regions, which are shown in Figure 4.12. The upper left region  was  found  to  be  split  into two; one to the left containing amino acids in β‐sheets and one to the right containing  the  amino  acids  in random  coil  of  this  conformation (Hovmoller,  Zhou  et  al.  2002). (Introduction  to  Protein  Structure, Brandan C., 1999, p.9).   
Figure  4.12:  A  general  view  of  the Ramachandran  plot,  to  show  possible conformations of φ and ψ angles. It is a way  to  visualize  dihedral  angles  φ against  ψ  of  amino  acid  residues  in protein structure.   
 
Figure  4.13:  Ramachandran  plot  of  the  collagen type1 α1 in complex with 8‐9 FnI 




   By  looking  at  the Ramachandran plot  of  our  crystal  it  is  obvious  to  see  that  all amino acids are in allowed regions (Figure 4.13). Most of the amino acids seemed to be involved in β‐ sheets. 
4.3.2.2 Structural analysis of 8­9FnI in complex with collagen type 1 α1 
“260”­site (G254 – Y277)  
By looking first at the two FN subunits, both 8FnI and 9FnI exhibit canonical FnI structures. Each domain has five strands, which are labelled A‐E in 8FnI and A’‐E’ in 9FnI. This fold is typical for the 8‐9FnI structure. By looking closer, it is possible to see a double and  a  triple‐stranded  anti‐parallel  β‐sheet  (strand  A,  B  and  C,  D,  E  and  D/E). Furthermore,  disulfide  bonds  between  the  strands  stabilize  the  structure  (stand  A/D and D/E). Figure 4.14 shows the 8‐9FnI and the right labelling of the strands.  
 For binding between the 8‐9FnI and collagen type 1 260‐site‐α1 sequence determinants are necessary, which include a hydrophobic residue in the first triplet and an absence of strand breaking (proline/4‐hydroxyproline) residues in the next two repeats. Thus basic 9‐mer pattern is found 11 times in collagen α1 chain and 17 times in collagen type 1 α2 chain. 
 
Figure  4.14:  Crystal  strucutre  of    8‐9FnI,  at  a  resolution  of  2.6  Å.  Every module consists out of five anti‐parallel β‐sheets. This is the typical fold for  8‐9FnI. The strucutre was first solved by Erat et al. (Erat, Slatter et al. 2009)  




 It is also interesting that by looking at the fold of 2‐3FnI in complex with another peptide from Staphylococcus aureus, a similar fold was found (Bingham, Rudino‐Pinera et al. 2008). Figure 4.15 shows the similarities between binding of collagen and bacterial peptides to FnI modules. They take on similar models of binding to FnI domains (Erat, Slatter  et  al.  2009). This  can  indicate  a  functional  similarity between  collagen and  the bacterial protein in interaction with FN. 





Figure 4.15: Overview of the interaction structure a) 8‐9FnI in complex with collagen type 1 260‐site‐α1 b)  8‐9FnI  in  complex  with  collagen  type  1  collagenase‐site‐α1  (Erat,  Slatter  et  al. 2009) c)  Similar  representation  of  2‐3FnI  in  complex with  a  peptide  from  Staphylococcus aureus. (Bingham, Rudino‐Pinera et al. 2008) Collagen and bacterial proteins bind in all cases in a simelar way to FnI modules. 








 b)                c) 
    
Figure 4.16: Interaction of 8‐9FnI in complex with collagen type 1 260‐site‐α1 (G254 – Y277) a) one copy of each molecule b) and c) different views of one asymmetric unit cell. In both copies the peptide residues G254 – Y277 align in an anti‐parallel β‐strand fashion to stand E on 8FnI to form an extension of the β‐sheet  Green:  8‐9FnI; Blue: collagen peptide  




 Figures 4.16b and 4.16c show different views of one asymmetric unit cell. In both copies the peptide residues G254 – Y277 align in an anti‐parallel β‐strand fashion to stand E on 8FnI to form an extension of the β‐sheet (Figure 4.16). This mode is often seen in protein  complexes.  The  8‐9FnI  conformation  is  stabilized  by  specific  hydrophobic contacts: One example  is  the  indole  ring of  8FnI W553, which  stacks  above  the peptide main  chain  over  residues  V520  and  G266.  Multiple  electrostatic  interactions  are  made, including several hydrogen bonds: (G254–W597, G254– H598, HYP262 – H539, M264 –C555, G266 –W553)  and  one  salt  bridge  to  8FnI  (R268  –  D516).    Collagen  residues  N‐terminal  to  the peptide  β‐strand  form  two  hydrogen  bonds  to  strand  E  of  the  9FnI  (G254–W597,  G254– H598).  Collagen  type  1  260‐site‐α1  has  one  4‐Hydroxy‐L‐Proline  in  each  copy.  These hydroxy‐prolines (HYP) are strand‐breaking residues. They are shown in Figure 4.17.  
  The  HYP262  side‐chain,  which  is  shown  in  Figure  4.17  and  Figure  4.18,  is sandwiched between those of D529 in the loop between strands B’ and C’ of 8FnI and Y525 in strand B’ of 9FnI. Figure 4.18 presents on the one hand HYP on the collagen type 1 α1 
a)               b) 
       
Figure 4.17: 4‐Hydroxy‐L‐Prolines (HYP) in Collagen type1 α1 ‐260 binding site a) in strand F b) in strand E. The collagen peptide has one HYP in each assymetrich unit. 









a)              b) 
   
Figure  4.19:  Glycosylation  site  on  N542  with  NAG  a)  in  Coot  it  is  possible  to  see  the interaction at an atomic level b) Pymol was used to show the interaction on the whole strand 






9FnI.  The  disulfide  bridges  are  done  by  cysteine‐cysteine  interaction.  In  the  8FnI  the disulfide  bridges  are  made  by  the  residues  C543  ‐  C555  and  C518‐  C545.  In  the  9FnI  the residues C561  – C  589 and C587 – C599 make  the disulfide bridges. These  interactions are important for the stability of 8‐9FN. They are shown in Figure 4.21.  
 
Figure 4.20: Looking at the surface of the FN collagen peptide complex. Here it is possible  to  see  the  structure  and  the positions of  the  two  interaction partners, one molecule  of  glyceron,  one  of  NAG  and  HYP.  Blue  is  the  collagen  typeI α1 peptide; green is the 8‐9FN, yellow is NAG, black glycerol and blue HYP. 








Figure 4.21: Disulfide bridges on the 8‐9FnI shown in orange                 a)  8FnI b)  9FnI There are only disulfide bridges on the  8‐9FnI. They help stailizing the whole conformation. 








Figure 4.22: Density map of one asymmetric unit. It is a possibility to see the  electronic  sourronding  of  the  complex.  This  map  describes  the contents of the unit cells averaged over the whole crystal. Green:   8‐9FnI; blue: Collagen peptide    
 
Figure 4.23:  Surface view of  the  8‐9Fn1  in  complex with collagen  type 1 260‐site‐α1  (G254 – Y277) Green:  8‐9FnI; blue: Collagen peptide   









Erat  et  al.  characterised  the  interaction  of  8‐9FnI  with  collagen  type  1  α1‐collagenase  site  (G778‐G799)  (Erat,  Slatter  et  al.  2009).  To  decipher  the  contribution  of individual factors to binding in detail, we used the information of the HSQC experiment of  the  interaction  of  8‐9FnI  with  collagen  type  1  α1‐collagenase  site  (G778‐G799)  for references.  Michèle  Erat  did  this  experiment.  We  tried  to  figure  out  the  influence  of temperature and of the sequence by doing several experiments, which are explained in the  following  chapter. 
  
Figure 4.24: NMR HSQC spectrum of  the  titration  8‐9FnI with collagen  type 1 collagenase‐site‐α1 (G778‐G799): A Kd‐value of 4.2 ± 0.8µM was calculatesd. The binding is tight; blue is 0.0 collagen peptide red is 4mM collagen peptide (Erat, Slatter et al. 2009)  




 The Kd‐value of this titration was calculated to be 4.2 ± 0.8µM. According to this the  binding  is  quite  tight  (Erat,  Slatter  et  al.  2009).  The  spectrum  is  shown  in  Figure 4.24.  
4.4.2. Binding studies by fluorescence measurement 
  The  sequence  of  the  collagen  type  1  collagenase‐site‐α1  was  tested  by fluorescence  anisotropy  titration  to bridge our  information between  the  long  collagen peptide  (298.1K)  and  the  short  ones  (310.1K).  Every  condition  of  different concentrations was tested at four different temperatures: 298.1K (25°C), 303.1K (30°C), 310.1K  (37°C)  and  315.1K  (42°C)  for  five  times.  Figure  4.25  shows  the  temperature influence on the interaction.  
 There  cannot  be  seen  a  huge  difference  between  each  temperature  step,  which  is  an indication that the length of the peptide as no relevance for binding. The table in Figure 4.25 shows the Kd‐values, which were calculated with the help of the program Origin 7.5 (Figure 4.26).   
Temperature  Kd‐value (µM) 298.1K (25°C)  4.58   ± 0.51  303.1K (30°C)  6.38   ± 0.71 310.1K (37°C)  9.46   ± 1.08 315.1K (42°C)  19.30 ± 2.52 
Figure  4.25:  Kd‐values  of  the  fluorescence anisotropy measurement 








After finding out that the peptide’s length does not play an important role for the interaction, we assumed that it has to be a sequential phenomenon. The sequence of the collagenase‐site‐α1 has two valine residues, V782 and V783. These two valines are in the crystal structure (Erat, Slatter et al. 2009) in an unfolded loop. The sequence of the 260‐site‐α1  has  no  valines  at  this  place  and  has weak  affinity  to  8‐9FnI.  The  idea was  that perhaps  these  two  valines  could  be  responsible  for  the  high  affinity  binding  on  the 
Figure  4.26:  Origin  data  of  the  fluorescence  anisotropy  titration  of  collagen  type  1 collagenase‐site‐α1  and  8‐9FnI.  It  is  obvious  to  see  that  there  are no big  differences  in  the different measurements. 





GQRGVSGLOGQRGERGFOGLOGY  and  GQRGSVGLOGQRGERGFOGLOGY.  GLOGQRGER  is the core sequence of the binding site. First  the  sequence  of  the  collagen  type  1  collagenase‐site‐α1  (VS‐mutation)  – 
GQRGVSGLOGQRGERGFOGLOGY –  was  tested.  Several  concentration  of  the  collagen peptide between 0.0mM and 0.6mM were done. The concentration of the 8‐9FnI protein was constant at 0.1mM. The temperature was 298.1K (25°C). With the help of the Origin data  the  Kd‐value  was  calculated  to  be  134  ±  19  µM.  A  1:1  biomolecular  model  is assumed. 
   
 
Figure 4.27: NMR HSQC spectrum of  the  titration  8‐9FnI with collagen  type 1 collagenase‐site‐α1 (G778‐G799) with the VS‐mutation. A Kd‐value of 134 ± 19 µM was obtained; blue is 0.0 collagen peptide green is 0.6mM collagen peptide 

















  The insert production went well. In the end we obtained a  product  at  the  right  size  of  224bp  with  the  sequence 
(GPP)6GIAGQRGVVGLPGQRGERGFPGLP(GPP)6Y.  The  insert was  ligated  into  the  amplified  pGEX‐6P‐2  vector  and transformed  into  SoloGoldPack  cells.  After  a  positive sequencing  result,  the  DNA  was  transformed  into  BL21‐CodonPlus (DE3)‐RIPL cells.  
4.5.3 Expression  and  purification  of  the 
triple helical peptide 
  After  a  successful  expression  in  minimal  media (Figure 4.30), purification was  started. For purification we  used  a  GST‐column  (Figure  4.31.).  Afterwards  we cleaved our out protein with 3c‐protease (Figure 4.32).  
 
Figure  4.29:  PCR product of 224bp, which is  used  as  the  insert  for the  production  of  the triple helical peptide.   
 
Figure  4.30:  Expression  of  the collagen type 1 peptide fragment in  the  vector  pGEX‐6P‐2.  The expected size is about 55kDa. By looking at the gel it is easy to see that  the  expression  worked  and that  the  fragment  is  at  the  right size. 





 By looking at Figure 4.31 and 4.32 a lot of GST is still visible. To discard the GST, we heated the sample up for 30min at 358.1K (85°C). The collagen peptide is very stable and starts precipitating at a temperature of approximately 368.1K (95°C). However, GST starts  precipitating  by  a  temperature  of  about  333.1K  (60°C).  So  it  was  possible  to precipitate GST out of solution, without harming our collagen peptide. After heating the sample  up, we  put  it  at  277.1K  (4°C)  over  night,  so  that  the  sample  could  cool  down again. After that step we used gelfiltation for our last purification step. There, the sample is loaded onto a gelfiltration column for purification. We used the column HiLoad 26/60 Superdex 75. So  it was possible  to separate  the collagen peptide  from the GST. This  is shown in Figure 4.32. Blue is the actual sample.  
 
Figure 4.31: GST‐purification    Figure 4.32: 3c‐protease cleavage of the peptide  GST‐purification was obtained to purify the triple helical peptide and only to get the peptide with  the  GST‐tag.  Figure  4.31  shows  the  protein‐rich  fractions,  which  were  pooled  . Afterwards  the GST‐tag was removed by 3c‐protease cleavage. Here it is exprected that the sample has a different molecular weight than the sample with the GST‐tag. This canbe seen in Figure 4.32. 







The  pure  sample  was  then  analysed,  to  make  sure  that  it  is  in  a  triple  helical formation. We  first  tried CD and measured  it at different  temperatures.  In Figure 4.34 two different CD spectra at 296.1K and 310.1K are shown. Both have a similar shape. CD was measured at:    
 
Figure 4.33: Gelfiltration spectrum. Eventhough we triesd hard to remove the GST, the gel‐filtration  step was  the  last  and  also most  efficient  step  to  get  rid  of most  of  the GST.  The collagen peptide came out after about 210ml, GST after 300ml. It was so easy to seperate the two main components; blue: peptide, brown: salt concentration,  




























α1 chain sequence, which is  just C‐terminal to the matrix metallopeptidase 1 (MMP‐1) cleavage site. According to this, Erat et al. suggested that FN stabilizes a non‐canonical collagen  structure  upon  binding,  leading  to  the  hypothesis  that  FN  binding  may influence collagen proteolysis, which  is  important  in growth, development,  repair, and cancerous  tumour  progression  (Kleinman  and  McGoodwin  1976;  Barilla  and  Carsons 2000;  Perumal,  Antipova  et  al.  2008). Erat  et.  al  have  solved  the  X‐ray  structure  of  a complex of 8‐9FnI bound to a collagen peptide of 23 amino acids to a resolution of 2.1 Å. This  collagen  peptide  adopts  an  anti‐parallel  β‐strand  conformation  in  the  complex, similar to structures of peptides from pathogenic bacteria bound to FN type 1 domains (Erat, Slatter et al. 2009), strengthening the notion that pathogenic bacteria may exploit the interaction between collagen and FN to invade tissues (Dinkla and Janssen 2003). By looking closer onto collagen type 1, two interaction sites were found on each α chain,  called  collagenase‐site  and 260‐site. High  affinity  binding  could  be  detected  for the collagenase‐site binding to the 8‐9FnI, and weak affinity binding for the 260‐site. The  “discussion‐chapter”  is  divided  into  four  subchapters.  The  first  three  characterise the  interaction  between  8‐9FnI  and  collagen  type  1.  The  last  subchapter  describes  the production of one triple helical peptide. 






As  it  is  known nowadays how  the  collagen  type 1 α1  collagenase  site  interacts with FN (Erat, Slatter et al. 2009), the question to ask is “how does FN interact with the 
α2 chain?”  According to Dr. Ioannis Vakonakis’ study about potential FN binding sites, both sequence for collagenase‐site‐α2, GAOGILGLOGSRGERGLOGVA, and for the 260‐site‐α2, GFOGTOGLOGFKGIRGHNGLD  and  the  260‐site‐α1,  GLOGTAGLOGMKGHRGFSGLDGY, fulfil the requirements, which are needed for binding. The bold letters describe at each sequence  the  core  binding  sequence.  Erat  et.  al  investigated  at  lot  of  work  in characterising  the  interaction of  8‐9FnI with  the  collagen  type 1  collagenase‐site  in α1 and α2 chain (Erat, Slatter et al. 2009). Therefore,  this diploma thesis concentrates on the binding between 8‐9FnI and collagen type 1 260‐site in α1 and α2 chain. We found out that the interaction of FN with collagenase‐site is tighter than with the 260‐site. The reason for that is that the starting‐sequence for the collagenase‐site, in both chains,  is more hydrophobic and  therefore  it  is more suitable  for  interaction. We tried to verify that by measuring the affinities of the interactions between the different collagen type 1 peptides in the α2 chain with 8‐9FnI. By looking at the different Kd‐values (Figure  5.1),  it  is  possible  to  see  the  two different  kinds  of  interaction  sites  and  their affinity for binding. 
 
Interaction site  Kd‐value  interaction “260”‐site α2 (GFOGTOGLOGFKGIRGHNGLD)  1.38 ± 0.17 mM  weak Core sequence of “260”‐site α2 (GLOGFKGIR)  2.27 ± 0.44 mM  Very weak Collagenase‐site α2 (GAOGILGLOGSRGERGLOGVA)  7.60 ± 1.4 µM  tight 
Figure 5.1: Kd‐values of interactionsites on collagen type 1 α2 with 8‐9FnI 




 According to this data it  is easy to see that the so‐called 260‐site‐α2, undergoes weak binding with 8‐9FnI. It is quite likely that the reason for that is a deficiency in the core‐sequence  of  this  interaction‐site,  as  nearly  no  perturbations,  thus  interactions, were detected in the NMR titration of that core with 8‐9FnI. 
5.3. Interaction of 8­9FnI with collagen type 1 260­site­α1  
As a second part of this thesis an interaction of 8‐9FnI with the 260‐site of collagen type 1 α1 chain is reported. We managed to obtain crystals  from the 8‐9FnI  in complex with collagen type 260‐ site‐α1 and determine the resulting structure at a resolution of 2.6Å. This site covers the residues G254 – Y277 (sequence: GLOGTAGLOGMKGHRGFSGY) binding  the  second  subfragment  of  the GBD,  8‐9FnI.  Through molecular  replacement  it we determined the structure. The tested collagen region has been shown to have a weak affinity  to  8‐9FnI,  binding with 125.45 ±  1.3 µM Kd.  The  crystal  structure  is  once more shown in Figure 5.2.  
 Although it was impossible to locate the residues D274 – Y277 in the structure, the overall  conformation  of  the  collagen  type  1  260‐site‐α1  peptide  is  similar  to  the  one 
 
Figure 5.2:  Crystal  structure of  8‐9FnI  in  complex with  collagen  type 1 260‐site‐α1  (G254  – Y277) 





     The  main  difference  between  these  two  structures  is  that  the  one  with  the collagenase‐site‐α1 has two valines in the central loop region, which is interacting with 
9FnI.  It  is quite  likely  that  these  two amino acids are  responsible  for  the much  tighter interaction with  the  8‐9FnI  than  the  260‐site  has.  This  question will  be  covered  in  the next sub‐chapter. 
5.4. Interaction of  8­9FnI with  collagen  type 1  collagenase­site­
α1  
By looking closer at the interaction of 8‐9FnI with the collagen type 1 collagenase‐site‐α1 we wanted to know how the tight interaction of 4.58 ± 0.51 µM is possible and what  is  responsible  for  that.  Erat  et  al.  characterised  that  interaction  by  using  the sequence  GQRGVVGLOGQRGERGFOGLOGY  (Erat,  Slatter  et  al.  2009).  The  bold  letters highlight the core‐binding‐sequence in the collagenase‐site‐α1.  
 
Figure 5.3: Crystal  structure of  the  8‐9FnI  in complex with collagen type 1 collagenase‐site‐α1 (Erat, Slatter et al. 2009) 




 The  first  idea was  to bridge our  information between  the  long collagen peptide (298.1K) and the short ones (310.1K) by using fluorescence anisotropy titration. The Kd‐values  then  showed  that  the  high  affinity  binding  is  not  influenced  by  the  peptide’s length. The Kd‐values are listed once again below (Figure 5.4).  
 The second  idea was  that  the  sequence might be  responsible  for an  increase of affinity.  The  sequence  is  GQRG1V2VGLOGQRGERGFOGLOGY.  There  are  evidences  that the  two  valines,  V782  and  V783,  are  necessary  for  binding  to  8‐9FnI.  So  two  different sequences  GQRGVSGLOGQRGERGFOGLOGY  and  GQRGSVGLOGQRGERGFOGLOGY,  were tested independently for binding. Valine is a hydrophobic amino acid, while serine is a hydrophilic amino acid and therefore would not contribute to the hydrophobic effect of binding as valine would. By putting a serine  instead of a valine  it makes  it possible  to detect the importance of one specific valine.  So, by looking at the different Kd‐values is it is possible to see that the valines are actually important for the high affinity binding of collagen type 1 collagenase‐site‐α1 to 8‐9FnI (Figure 5.6).  
Temperature  Kd‐value (µM) 298.1K (25°C)  4.58   ± 0.51  303.1K (30°C)  6.38   ± 0.71 310.1K (37°C)  9.46   ± 1.08 315.1K (42°C)  19.30 ± 2.52 Figure  5.4:  Kd‐values  of  the  fluorescence anisotropy measurement 





 It  seems  that  the  V783  has  a  higher  influence  on  the  binding  than  V782.  But basically both valines are needed so that a thigh interaction is possible.  
5.5. Production of a triple helical collagen peptide 
Furthermore  we  tried  to  produce  one  triple‐helical  collagen  peptide  with  the sequence (GPP)6GIAGQRGVVGLPGQRGERGFPGLP(GPP)6 Y by bacterial expression. This sequence  is  the  collagen  type  1  collagenase‐site‐α1,  but  it  has  prolines  instead  of hydroxyprolines. The idea was to be able to produce labelled peptide for NMR studies. After a successful production of this peptide, we tried to analyse it. We first did this by measuring  the  CD  signal  in  search  for  triple‐helical  properties. We  used  this method, because a correctly folded collagen peptide will give a different spectrum then any other conformation.  This  is  described  by  N.J.  Greenfield  (Greenfield  2006).  The  spectra  are given, which  indicates every specific  case of  folding  (Figure 5.7). Figure 5.8 shows  the spectrum of our own produced collagen peptide. 
Sequence  Kd‐values GVV  4.2   ±  0.8µM GVS  134  ±  19µM GSV  15.9 ± 1.1µM 
Figure 5.6: Kd‐values of different collagenase‐site‐α1 peptides 





  While comparing these two spectra is it not really obvious if the collagen peptide is  totally  in  triple  helical  conformation.  So  we  did  MASSPEC,  to  make  sure,  that  we produced the peptide in the right way. The right molecular weight (MW) proves this. As said in the 4th chapter “Results” the expected MW is 5554.3 Da. According to MASSPAC the  actually MW  is  5578Da. We assume  that  this  is  due  to  a  salt  adduct,  because MW (Na)=23Da. So our conclusion is that we produced the peptide in the right way, but for some reason it is not totally folded in a triple‐helical way. Therefore one future‐plan is to figure the triple‐helical conformation out by using NMR.     
 
Figure  5.7:  CD‐spectra  for  collagen  (Greenfield 2006) 
 
Figure  5.8:  CD  spectra  of  the  produced collagen peptide at 310K (37°C) 
















   Adams, P. D., R. W. Grosse‐Kunstleve, et al. (2002). "PHENIX: building new software for automated  crystallographic  structure  determination."  Acta  Crystallogr  D  Biol Crystallogr 58(Pt 11): 1948‐54. Balian,  G.,  E.  M.  Click,  et  al.  (1980).  "Location  of  a  collagen‐binding  domain  in fibronectin." J Biol Chem 255(8): 3234‐6. Barilla,  M.  L.  and  S.  E.  Carsons  (2000).  "Fibronectin  fragments  and  their  role  in inflammatory arthritis." Semin Arthritis Rheum 29(4): 252‐65. Bingham, R. J., E. Rudino‐Pinera, et al. (2008). "Crystal structures of fibronectin‐binding sites  from Staphylococcus aureus FnBPA  in complex with  fibronectin domains." Proc Natl Acad Sci U S A 105(34): 12254‐8. Bocquier, A. A., J. R. Potts, et al. (1999). "Solution structure of a pair of modules from the gelatin‐binding domain of fibronectin." Structure 7(12): 1451‐60. Bright, J. R., A. R. Pickford, et al. (2000). "Preparation of isotopically labeled recombinant fragments  of  fibronectin  for  functional  and  structural  study  by  heteronuclear nuclear magnetic resonance spectroscopy." Methods Mol Biol 139: 59‐69. Brodsky,  B.  and  J.  Baum  (2008).  "Structural  biology:  Modelling  collagen  diseases." Nature 453(7198): 998‐9. Cereghino,  J.  L.  and  J.  M.  Cregg  (2000).  "Heterologous  protein  expression  in  the methylotrophic yeast Pichia pastoris." FEMS Microbiol Rev 24(1): 45‐66. Chung,  J.  D.  (2000).  "Design  of metabolic  feed  controllers:  application  to  high‐density fermentations of Pichia pastoris." Biotechnol Bioeng 68(3): 298‐307. Cordingley,  M.  G.,  R.  L.  LaFemina,  et  al.  (1990).  "Sequence‐specific  interaction  of  Tat protein and Tat peptides with  the  transactivation‐responsive sequence element of  human  immunodeficiency  virus  type  1  in  vitro."  Proc  Natl  Acad  Sci  U  S  A 
87(22): 8985‐9. Cregg, J. M., K. R. Madden, et al. (1989). "Functional characterization of the two alcohol oxidase genes from the yeast Pichia pastoris." Mol Cell Biol 9(3): 1316‐23. Dessau, W., J. Sasse, et al. (1978). "Synthesis and extracellular deposition of fibronectin in  chondrocyte  cultures.  Response  to  the  removal  of  extracellular  cartilage matrix." J Cell Biol 79(2 Pt 1): 342‐55. Dinkla, I. J. and D. B. Janssen (2003). "Simultaneous growth on citrate reduces the effects of  iron  limitation  during  toluene  degradation  in  Pseudomonas."  Microb  Ecol 
45(1): 97‐107. Dzamba,  B.  J.  and  D.  M.  Peters  (1991).  "Arrangement  of  cellular  fibronectin  in noncollagenous fibrils in human fibroblast cultures." J Cell Sci 100 ( Pt 3): 605‐12. Dzamba, B. J., H. Wu, et al. (1993). "Fibronectin binding site in type I collagen regulates fibronectin fibril formation." J Cell Biol 121(5): 1165‐72. Emsley, P.  and K. Cowtan  (2004).  "Coot: model‐building  tools  for molecular  graphics." Acta Crystallogr D Biol Crystallogr 60(Pt 12 Pt 1): 2126‐32. Engvall,  E.  and  E.  Ruoslahti  (1977).  "Binding  of  soluble  form  of  fibroblast  surface protein, fibronectin, to collagen." Int J Cancer 20(1): 1‐5. Erat, M.  C.,  D.  A.  Slatter,  et  al.  (2009).  "Identification  and  structural  analysis  of  type  I collagen sites  in  complex with  fibronectin  fragments." Proc Natl Acad Sci U S A 
106(11): 4195‐200. Eyre, D. R. (1980). "Collagen: molecular diversity in the body's protein scaffold." Science 
207(4437): 1315‐22. 




 Gabbiani,  G.  (2003).  "The  myofibroblast  in  wound  healing  and  fibrocontractive diseases." J Pathol 200(4): 500‐3. Geiger,  B.,  A.  Bershadsky,  et  al.  (2001).  "Transmembrane  crosstalk  between  the extracellular matrix‐‐cytoskeleton  crosstalk." Nat Rev Mol  Cell  Biol 2(11):  793‐805. Gelse, K., E. Poschl, et al. (2003). "Collagens‐‐structure, function, and biosynthesis." Adv Drug Deliv Rev 55(12): 1531‐46. Granelli‐Piperno, A., B. Moser, et al. (1996). "Efficient interaction of HIV‐1 with purified dendritic cells via multiple chemokine coreceptors." J Exp Med 184(6): 2433‐8. Greenfield, N. J. (2006). "Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions." Nature protocols. Harper  S.  and  S.  D. W.  (2008).  "Expression  and  Purification  of  GST  Fusion  Proteins." Current Protocols in Protein Science Unit 6.6. Hovmoller,  S.,  T.  Zhou,  et  al.  (2002).  "Conformations  of  amino  acids  in  proteins." Acta Crystallogr D Biol Crystallogr 58(Pt 5): 768‐76. Hynes, R. (1985). "Molecular biology of fibronectin." Annu Rev Cell Biol 1: 67‐90. Hynes,  R.  O.  (1985).  "Fibronectins:  a  family  of  complex  and  versatile  adhesive glycoproteins derived from a single gene." Harvey Lect 81: 133‐52. Ingham, K. C., S. A. Brew, et al. (1988). "Interaction of fibronectin and its gelatin‐binding domains with fluorescent‐labeled chains of type I collagen." J Biol Chem 263(10): 4624‐8. Jarymowycz,  V.  A.  and  M.  J.  Stone  (2006).  "Fast  time  scale  dynamics  of  protein backbones: NMR relaxation methods, applications, and functional consequences." Chem Rev 106(5): 1624‐71. Johnson,  K.  J.,  H.  Sage,  et  al.  (1999).  "The  compact  conformation  of  fibronectin  is determined by intramolecular ionic interactions." J Biol Chem 274(22): 15473‐9. Kadler,  K.  E.,  A.  Hill,  et  al.  (2008).  "Collagen  fibrillogenesis:  fibronectin,  integrins,  and minor  collagens  as  organizers  and  nucleators."  Curr Opin  Cell  Biol 20(5):  495‐501. Khew, S. T. and Y. W. Tong (2007). "Characterization of triple‐helical conformations and melting analyses of  synthetic  collagen‐like peptides by  reversed‐phase HPLC."  J Chromatogr B Analyt Technol Biomed Life Sci 858(1‐2): 79‐90. Kilis‐Pstrusinska,  K.,  I.  Wikiera‐Magott,  et  al.  (2002).  "Analysis  of  collagen  IV  and fibronectin in blood and urine in evaluation of nephrotic fibrosis in children with chronic glomerulonephritis." Med Sci Monit 8(10): CR713‐9. Kleinman, H. K. and E. B. McGoodwin (1976). "Localization of the cell attachment region in types I and II collagens." Biochem Biophys Res Commun 72(2): 426‐32. Kleinman, H. K., E. B. McGoodwin, et al. (1978). "Localization of the binding site for cell attachment in the alpha1(I) chain of collagen." J Biol Chem 253(16): 5642‐6. Kornblihtt,  A.  R.,  K.  Umezawa,  et  al.  (1985).  "Primary  structure  of  human  fibronectin: differential  splicing may  generate  at  least  10 polypeptides  from a  single  gene." EMBO J 4(7): 1755‐9. Kuivaniemi, H., G. Tromp, et al. (1991). "Mutations in collagen genes: causes of rare and some common diseases in humans." FASEB J 5(7): 2052‐60. Kuivaniemi, H., G. Tromp, et al.  (1997).  "Mutations  in  fibrillar collagens  (types  I,  II,  III, and XI), fibril‐associated collagen (type IX), and network‐forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels." Hum Mutat 
9(4): 300‐15. 




 Leitinger,  B.  and  E.  Hohenester  (2007).  "Mammalian  collagen  receptors."  Matrix  Biol 
26(3): 146‐55. Magnusson,  M.  K.  and  D.  F.  Mosher  (1998).  "Fibronectin:  structure,  assembly,  and cardiovascular implications." Arterioscler Thromb Vasc Biol 18(9): 1363‐70. Mao,  Y.  and  J.  E.  Schwarzbauer  (2005).  "Fibronectin  fibrillogenesis,  a  cell‐mediated matrix assembly process." Matrix Biol 24(6): 389‐99. McCoy, A. J. (2007). "Solving structures of protein complexes by molecular replacement with Phaser." Acta Crystallogr D Biol Crystallogr 63(Pt 1): 32‐41. McMullen,  B.  A.  and  K.  Fujikawa  (1985).  "Amino  acid  sequence  of  the  heavy  chain  of human alpha‐factor XIIa (activated Hageman factor)." J Biol Chem 260(9): 5328‐41. Meenan, N. A., L. Visai, et al. (2007). "The tandem beta ‐zipper model defines high affinity fibronectin‐binding repeats within Staphylococcus aureus FnBPA." J Biol Chem. Midwood, K.  S.,  L. V. Valenick,  et  al.  (2004).  "Coregulation of  fibronectin  signaling  and matrix contraction by tenascin‐C and syndecan‐4." Mol Biol Cell 15(12): 5670‐7. Millard, C. J., I. D. Campbell, et al. (2005). "Gelatin binding to the 8F19F1 module pair of human  fibronectin  requires  site‐specific  N‐glycosylation."  FEBS  Lett  579(20): 4529‐34. Monti, S., S. Bronco, et al.  (2005).  "Toward the supramolecular structure of collagen: a molecular dynamics approach." J Phys Chem B 109(22): 11389‐98. Morrison,  P.  R.,  J.  T.  Edsall,  et  al.  (1948).  "Preparation  and  properties  of  serum  and plasma proteins;  the separation of purified  fibrinogen  from fraction  I of human plasma." J Am Chem Soc 70(9): 3103‐8. Mosher, D. F. and P. E. Schad (1979). "Cross‐linking of  fibronectin to collagen by blood coagulation Factor XIIIa." J Clin Invest 64(3): 781‐7. Nagarajan, V., S. Kamitori, et al. (1999). "Structure analysis of a collagen‐model peptide with a (Pro‐Hyp‐Gly) sequence repeat." J Biochem 125(2): 310‐8. Novokhatny,  V.  V.  and K.  C.  Ingham  (1994).  "Domain‐Structure  of  the  Fib‐1  and  Fib‐2 Regions of Human Fibronectin ‐ Thermodynamic Properties of the Type‐I Finger Module." Journal of Molecular Biology 238(5): 833‐844. Okuyama, K. (2008). "Revisiting the molecular structure of collagen." Connect Tissue Res 
49(5): 299‐310. Perumal, S., O. Antipova, et al. (2008). "Collagen fibril architecture, domain organization, and triple‐helical conformation govern its proteolysis." Proc Natl Acad Sci U S A 
105(8): 2824‐9. Pickford, A. R., S. P. Smith, et al.  (2001). "The hairpin structure of the (6)F1(1)F2(2)F2 fragment  from  human  fibronectin  enhances  gelatin  binding."  Embo  Journal 
20(7): 1519‐1529. Potterton, E., S. McNicholas, et al.  (2002).  "The CCP4 molecular‐graphics project." Acta Crystallogr D Biol Crystallogr 58(Pt 11): 1955‐7. Potts,  J. R. and  I. D. Campbell  (1994).  "Fibronectin structure and assembly." Curr Opin Cell Biol 6(5): 648‐55. Potts,  J. R.  and  I. D. Campbell  (1996).  "Structure and  function of  fibronectin modules." Matrix Biol 15(5): 313‐20; discussion 321. Powell, H. R. (1999). "The Rossmann Fourier autoindexing algorithm in MOSFLM." Acta Crystallogr D Biol Crystallogr 55(Pt 10): 1690‐5. Raines,  E.  W.  (2000).  "The  extracellular  matrix  can  regulate  vascular  cell  migration, proliferation,  and  survival:  relationships  to  vascular  disease."  Int  J  Exp  Pathol 
81(3): 173‐82. 




 Ramachandran, G. N. (1963). "Molecular Structure of Collagen." Int Rev Connect Tissue Res 1: 127‐82. Ramachandran,  G. N.,  C.  Ramakrishnan,  et  al.  (1963).  "Stereochemistry  of  polypeptide chain configurations." J Mol Biol 7: 95‐9. Raman, S. S., R. Parthasarathi, et al.  (2006). "Role of aspartic acid  in collagen structure and  stability:  A  molecular  dynamics  investigation."  J  Phys  Chem  B  110(41): 20678‐85. Rich, A. and F. H. Crick (1961). "The molecular structure of collagen." J Mol Biol 3: 483‐506. Rossert,  J.,  C.  Terraz,  et  al.  (2000).  "Regulation  of  type  I  collagen  genes  expression." Nephrol Dial Transplant 15 Suppl 6: 66‐8. Rostagno, A., M. J. Williams, et al. (1994). "Further characterization of the NH2‐terminal fibrin‐binding site on fibronectin." J Biol Chem 269(50): 31938‐45. Rovin,  B.,  J.  Molnar,  et  al.  (1984).  "Interaction  of  plasma  fibronectin  (pFN)  with membranous  constituents  of  peritoneal  exudate  cells  and  pulmonary macrophages." J Leukoc Biol 36(5): 601‐20. Ruoslahti, E. (1988). "Fibronectin and its receptors." Annu Rev Biochem 57: 375‐413. Ruoslahti, E., A. Pekkala, et al. (1979). "Effect of dextran sulfate on fibronectin‐collagen interaction." FEBS Lett 107(1): 51‐4. Schwarz‐Linek,  U.,  J.  M.  Werner,  et  al.  (2003).  "Pathogenic  bacteria  attach  to  human fibronectin through a tandem beta‐zipper." Nature 423(6936): 177‐81. Schwarzbauer, J. E. and J. L. Sechler (1999). "Fibronectin fibrillogenesis: a paradigm for extracellular matrix assembly." Curr Opin Cell Biol 11(5): 622‐7. Sechler,  J.  L.,  H.  Rao,  et  al.  (2001).  "A  novel  fibronectin  binding  site  required  for fibronectin fibril growth during matrix assembly." J Cell Biol 154(5): 1081‐8. Sechler,  J.  L.,  Y.  Takada,  et  al.  (1996).  "Altered  rate  of  fibronectin matrix  assembly  by deletion of the first type III repeats." J Cell Biol 134(2): 573‐83. Sengupta, P., Y. Xu, et al. (2005). "Collagen alpha1(I) gene (COL1A1) is repressed by RFX family." J Biol Chem 280(22): 21004‐14. Shimizu, M.,  K. Minakuchi,  et  al.  (1997).  "Difference  in  interaction  of  fibronectin with type I collagen and type IV collagen." Biochim Biophys Acta 1339(1): 53‐61. Sivakumar, P., A. Czirok, et al. (2006). "New insights into extracellular matrix assembly and  reorganization  from  dynamic  imaging  of  extracellular  matrix  proteins  in living osteoblasts." J Cell Sci 119(Pt 7): 1350‐60. Solomon,  E.,  L.  Hiorns,  et  al.  (1984).  "Confirmation  that  the  type  I  collagen  gene  on chromosome 17 is COL1A1 (alpha 1(I], using a human genomic probe." Ann Hum Genet 48(Pt 1): 39‐42. Sottile,  J.  and  D.  C.  Hocking  (2002).  "Fibronectin  polymerization  regulates  the composition  and  stability  of  extracellular  matrix  fibrils  and  cell‐matrix adhesions." Mol Biol Cell 13(10): 3546‐59. Sreekrishna,  K.,  R.  G.  Brankamp,  et  al.  (1997).  "Strategies  for  optimal  synthesis  and secretion of heterologous proteins  in  the methylotrophic yeast Pichia pastoris." Gene 190(1): 55‐62. Taylor, D. B. and T. K. Gartner (1992). "A peptide corresponding to GPIIb alpha 300‐312, a  presumptive  fibrinogen  gamma‐chain  binding  site  on  the  platelet  integrin GPIIb/IIIa,  inhibits  the adhesion of platelets  to at  least  four adhesive  ligands."  J Biol Chem 267(17): 11729‐33. 




 Vagin,  A.  A.,  R.  A.  Steiner,  et  al.  (2004).  "REFMAC5  dictionary:  organization  of  prior chemical  knowledge  and  guidelines  for  its  use."  Acta  Crystallogr  D  Biol Crystallogr 60(Pt 12 Pt 1): 2184‐95. Vakonakis, I. and I. D. Campbell (2007). "Extracellular matrix: from atomic resolution to ultrastructure." Curr Opin Cell Biol 19(5): 578‐83. van der Rest, M.  and R. Garrone  (1991).  "Collagen  family  of  proteins."  FASEB  J 5(13): 2814‐23. Walker,  P.  A.,  L.  E.  Leong,  et  al.  (1994).  "Efficient  and  rapid  affinity  purification  of proteins using recombinant fusion proteases." Biotechnology (N Y) 12(6): 601‐5. Wang,  A.  Y.,  X. Mo,  et  al.  (2005).  "Facile modification  of  collagen  directed  by  collagen mimetic peptides." J Am Chem Soc 127(12): 4130‐1. Williams, M.  J.,  I. Phan, et al.  (1994).  "Solution structure of a pair of  fibronectin  type 1 modules with fibrin binding activity." J Mol Biol 235(4): 1302‐11.   Bruce Alberts et. al. ‐ Molecular Biology of the Cell, 4th Edition (2002) Brandan C ‐ Introduction to Protein Structure (1999) J. Keeler ­ Understanding NMR Spectroscopy (2006)  M.H. Levitt ‐ Spin Dynamics – Basics of Nuclear Magnetic Resonance (2008).  D. Blow ‐ “Outline of Crystallography for Biologists” (2002) G.  Rhodes  ‐  “Crystallography made  crystal  clear  –  a  guide  for  Users  of Macromolecular 














The  theory  of  NMR  technique  is  well  described  in  the  books  Understanding  NMR 
Spectroscopy (J. Keeler, 2006) and Spin Dynamics – Basics of Nuclear Magnetic Resonance (M.H. Levitt, 2008). A very good review about dynamics of protein backbones is written by  V.  A.  Jarymowycz  and M.  J.  Stone  (Jarymowycz  and  Stone  2006).  The  information given in this “NMR part” are based on various parts of the two aforementioned books as well as on various parts of  the dissertations, written by Sachchidanand, 2001(Heparin Binding  to  Fibronectin)    and  Robin Michael  Schlinkert,  2005  (The  structural  basis  of Fibronectin – Integrin interactions)  The  theory  of  crystallography  is  based  on  the  books  “Outline  of  Crystallography  for 
Biologists” (D. Blow, 2002) and in the book “Crystallography made crystal clear – a guide 
for  Users  of  Macromolecular  Models”  (G.  Rhodes,  2006).  Furthermore  I  used  the disseration, written by Julie Welburn, 2005 (Structural and functional aspects of protein regulation by phosphorylation) 
A­1 Nuclear magnetic resonance (NMR) as technique 
A­1.1 Introduction 
Nowadays  NMR  spectroscopy  is  one  of  the  best  methods  to  study  different aspects of chemistry, biology and medicine. NMR makes use of the fact that some nuclei possess nuclear spin. The nuclear spin systems have unique properties that predestine them for studies of molecules; the atomic nuclei in a molecule serve as sensors and are extremely well localized, with a diameter of a few femtometers. Solution phase NMR study  is  the most  important one which biochemists use.  It allows additional  insight  into dynamic phenomena.  It  is  the complementary method to 




 X‐ray  crystallography.  This  technique  lacks  the  ability  to monitor  both  ligand  binding and intrinsic proteins dynamics. For flexible proteins NMR is the method of choice. The flexibility in NMR experiments of proteins under various conditions of pH, temperature, ionic  strength  and  buffers  allow  comparative  studies  under  native  and  denaturing solution conditions, and investigations of intermolecular interactions with other soluble molecules. 
A­2 Principles of NMR 
NMR  is  a  physical  resonance  phenomenon, which  is  based  on  the  fact  that  the magnetic moment of nuclei with nuclear spin becomes aligned in strong magnetic fields (2‐14 Tesla) allowing the spins to interact with an applied electromagnetic radiation in the  radio  frequencies  range.  It  is  involved  in  the  observation  of  specific  quantum mechanical  magnetic  properties  of  an  atomic  nucleus  in  the  presence  of  an  applied, external magnetic field. Like all other forms of spectroscopy, an NMR spectrum is a plot of the intensity of absorption (or emission) on the vertical axis against frequency on the horizontal axis.  The  quantum  mechanical  property  of  the  spin  is  the  source  of  angular momentum,  instrinsic  to  a number of different nuclei. The  spin angular momentum  is characterised by nuclear spin quantum numbers (I), which can have values I=0, ½, 1, 1 ½, …etc (Figure 2.2). For NMR spectroscopy of biomolecules the most important nuclei are the ones with   I = ½ such as 1H, 13C, 15N and 31P. The most important nucleus with I=1  is  Deuteron  (2H).    The  common  biological  nuclei  such  as  12C  or  16O  have  I=0  and therefore do not give any NMR spectra. 







γ ….. gyromagnetic ratio I ….. angular momentum ,  and  is  collinear with  the  vector  representation  the  nuclear  spin  angular momentum vector. The gyromagnetic  ratio γ  is  the proportionality  constant which determines  the resonant  frequency  of  the  nucleus  for  a  given  external  field  and  the  spin  angular momentum, I, is a vector quantity with magnitude given by  
        
By convention, the value of the z component of I is specified by the equation   
 
Figure A­1.2.1  a)  Schematic  representation of  the motion of  the nucleus on a magnetic field.         b)  Angular  momentum  vectors,  I,  and  the  allowed  z  components,  I(z),  for  a  spin  –  ½ particle 




 Thus  I(z)  has  2I+1  possible  values.  The  orientation  of  the  spin  angular  momentum vector is quantized, as the magnitude of the vector is constant and the z component has a  set  of  discrete  values.    For  an  isolated  spin  in  the  absence  of  external  fields,  the quantum  states  corresponding  to  the 2I+1  values  of m have  the  same  energy  and  the spin angular momentum vector does not have a preferred orientation. In the presence of an external magnetic field, the spin states of the nucleus have energies given by  E= ‐µB,      E ….. energy of the spin states     B ….. magnetic field vector Since  ,  µ  cannot  be  collinear  with  B  and  the m  spin  states  become  quantized with  energies proportional  to  their  projection  onto  B.  In  a  high‐field  NMR  spectrometer,  the  static external  field  is directed along  the z‐axis of the  laboratory  coordinates  system. For  this geometry    ,    B0 ….. static magnetic field strength    In  the  presence  of  static  magnetic field,  the  projections  of  the  angular momentum  of  the  nuclei  onto  z‐axis  of  the laboratory  frame  results  in  2I+1  equally spaced  energy  levels,  which  are  known  as 
  
Figure  A­1.2.2:  Energy  separation between nuclear spin states 




 Zeeman levels. For I= ½ 1H there will be two equally spaced energy levels with m1= + ½ (α) and – ½ (β).  The “nuclear” magnetic moment precesses about the field direction at a rate  known  as  the  Larmor  frequency  ω0=  γB0.  This  is  proportional  to  the  field experienced by  the nucleus  and  is  dependent  on  the  electron  clouds  that  surround  it. The exact magnitude of this shielding effect depends on the nature of the molecule. The precession  axis  is  either  aligned  parallel  or  anti‐parallel  to  the  magnetic  field.  The parallel  alignment  corresponds  to  the  lower  energy  level  and  the  anti‐parallel  to  the higher energy level (Figure A‐1.2.2).  In a sample containing a  large number of spins at thermal  equilibrium,  there  will  be  a  difference  in  the  populations  of  the  two  energy 
levels according to the Boltzmann distribution.       Nα …. α parallel spin state      Nβ ….. β anti‐parallel spin state    kBT .…. Thermal energy   Along  the z‐axis  there  is a net magnetisation of  the sample parallel  to  the  field. The  magnetic  field,  B0,  defines  the  z’‐axis  of  the  coordinate  system  known  as  the laboratory frame. The magnetic moments of the individual nuclei also have components of  magnetisation  in  the  x’‐y’‐plane.  However,  at  equilibrium  there  is  no  preferred orientation  in  this  plane,  so  the  phase  of  precession  is  random  and  there  is  no  net magnetization in the x’ –y’ plane and total magnetization of the sample is stationary and aligned with the z’‐axis. 






A crystal  is  an ordered array of molecules packed  into  a  lattice. The process of crystallisation consists of two major events, nucleation and crystal growth. Nucleation is the process where the solute molecules dispersed in the solvent start to accumulate into clusters.  Afterwards,  they  become  stable  under  the  current  conditions.  These  stable clusters constitute the nuclei. However, when the clusters are not stable, the molecules re‐dissolve.  Therefore,  the  clusters  need  to  reach  a  critical  size  so  that  they  become stable  nuclei.  At  this  stage  of  nucleation  the  atoms  arrange  in  a  defined  and  periodic manner that defines the crystal structure. The second step of the crystallisation process is the crystal growth, is which the nuclei grow. Nucleation and growth continue to occur simultaneously while the supersaturation exists. Supersaturation is the driving force of crystallization. Supersaturation happens when the saturated solution of protein ‐  in an aqueous buffer  ‐  is mixed with a precipitant  in a sealed environment. The presence of concentrated  precipitant  at  a  concentration  must  be  below  the  protein  precipitation point. Water will then slowly diffuse out of the drop and resulting in the concentration of the protein solution. Supersaturated solutions of molecules are in a thermodynamically unstable state, which drives crystal nucleation as well as protein precipitation. Figure A‐2.1 shows how nucleation and growth are dependent on each other. 





 Depending on the conditions, either nucleation or growth is predominant over the other. Crystals  can be  formed when  the protein concentration  is above  the protein solubility curve  und  nucleation  conditions.  When  the  energy  barrier  overcomes  the  nucleation process initiates crystal growth. As a result crystals with different sizes and shapes are collected. Once the supersaturation is over, the solid‐liquid system reaches equilibrium and the crystallization is complete.  
A­2.1 Crystal and symmetry 
Atoms and molecules are arranged  in a regular array  to  form a crystal. The  flat faces  and  sharp  edges  of  crystals  reflect  the  high  order  of  molecules  in  crystals.  The smallest repeat in the crystal is the asymmetric unit. Depending on the symmetry of the crystal  and  its  space‐group,  there  can  be  more  than  one  per  unit  cell.  The  smallest repeated unit in the crystal is the unit cell. The content of every unit cell is identical and 
 
Figure A­2.1:  Solubility  curve  for  a protein as  a  function of precipitant concentration: For the best results the crystals should be grown at a level just  under  supersaturation.  Nucleation  initiates  crystal  growth,  which proceeds in the metastable zone.  




 repeated  in  a  regular  array  throughout  the  crystal.  The  unit  cell  is  defined  by  three repeating vectors a, b and c, and separated by α, β and γ angles. Ideally, the content of every cell is identical throughout the crystal and each cell is in a similar environment.  By  convention,  the  crystallographic  a,  b  and  c  axes  should  correspond  as  much  as possible with  the direction of highest symmetry axis. The  fundamental requirement of the  unit  cell  edges  a,  b  and  c  is  that  they  provide  a  set  of  basis  vectors  that  span  the crystal lattice, with repeating units separated by integral steps. Certain space‐groups are defined  with  more  than  one  primitive  unit  within  the  unit  cell  with  the  extra  lattice point(s) found at the centre of either one unit cell face (C centring), all unit cell faces (F centring),  or  at  the  intersection  of  the  body  diagonal  of  the  unit  cell  (I  centred).  A primitive unit cell is shown in Figure A‐2.1.1.           Crystals  can  be  classified  into  seven  different  classes  based  on  the  point  group symmetry.  The  symmetry  elements  put  some  relationships  between  the  different  cell edges and angles in place. Based on the geometrical restrictions, which is implied by the point group symmetry and the translational symmetry arising from the type of unit cell, the fourteen types of the Bravais lattices can be built up (Figure A‐2.1.2). Rotation and 
 
Figure A­2.1.1: One primitive unit cell 














Diffraction of an object ‐ by an electromagnetic wave ‐ gives a diffraction pattern, which  corresponds  to  the  Fourier  transformation  of  that  object.  X‐rays  are  used  to visualise  atomic  details  of  molecules  and  the  principles  are  similar  to  that  of  light microscopy.  However,  no  lens  can  focus  x‐ray  radiation.  It  is  possible  to  record  the amplitudes of the X‐rays scatters by the crystal with great accuracy but the phases are lost. This  is known as the phase problem. To obtain the phase  in order to reconstitute the  structure  of  the  molecules  of  interest,  phasing  information  and  computational calculations are required.  The  main  goal  of  X‐ray  crystallography  is  to  determine  the  density  of  electrons  fr throughout the crystal, where r represents the three‐dimensional position vector within the crystal. To do so, X‐ray scattering is used to collect data about its Fourier transform Fq, which  is  inverted mathematically  to obtain  the density defined  in  real  space, using 
the equation  
The Fourier transform Fq is a complex number, and therefore has a magnitude |Fq| and a phase Fq related by the equation  The  intensities  of  the  reflections, which  can  be  observed  in  X‐ray  diffraction,  give  the magnitudes |Fq| but not the phases φq.  Even though crystals are often idealized as being perfectly periodic, they are not so  in  reality.  Atoms  vibrate  about  their mean  position,  and  there may  be  disorder  of various  types,  for  example  mosaicity,  dislocations,  various  point  defects,  and heterogeneity in the conformation of crystallized molecules. Therefore, the Bragg peaks 




 have  a  finite  width  and  there  may  be  significant  diffuse  scattering,  a  continuum  of scattered X‐rays that fall between the Bragg peaks. 1913 Bragg identified the conditions of X‐ray diffraction by a crystal. In his model a given reflection  is associated with a set of evenly spaced sheets running through the crystal,  usually  passing  through  the  centres  of  the  atoms  of  the  crystal  lattice.  The scattering of X‐rays by the crystal can be described as reflections from sets of planes of atoms.  Planes  can  be  constructed  through  the  lattice  points  which  can  be  defined  by three integer numbers known as the Miller indices h, k and l. The lattice planes cut a, b and  c  in  a/h,  b/k  and  c/l  pieces.  X‐ray  diffraction  is  obtained when  the  planes  of  the lattices  in  accordance  with  Bragg’s  law  reflect  the  X‐rays.  The  X‐rays  scattered  by different  lattices  points  in  a  same  plane  must  be  in  phase  to  obtain  constructive interference  (with  a  phase  difference  Δφ=2πn),  corresponding  to  a  reflection  in  the diffraction pattern. The two X‐rays scattered by a plane (h, k,  l) will yield constructive interference when the path difference between the two x‐rays is multiple integral of the wavelength of the incident beam giving:     d……distance between parallel reflecting planes 
λ……the incident wavelength of X‐rays n……an integar number  
θ……the angle of the incident X‐ray beam During  an  experiment  the  wavelength  is  fixed,  to  after  rearranging  the  equation  the determine the minimum spacing, the equation is  
 






















































































2. Pipette  25µL  of  TE  buffer  (10mM  Tris,  1mM  EDTA,  pH  8.0)  into  10  PCR  tubes (0.2mL). 3. Select  10  bacterial  colonies  from  the  plate(s)  you  wish  to  screen,  and  transfer  a sample of each into one of the PCR tubes.  When you do this, it is very important that you do not remove the entire colony!   It is equally important that you mark and 




Mastermix for 10 
colonies (12x)* 
Mastermix for 15 
colonies (17x)* 
Mastermix for 18 
colonies (20x)* 
dH2O 17.5 210 297.5 350 
10x Thermopol buffer 
(from Vent kit) 2.5 30 42.5 50 
MgSO4 (from Vent kit) 1 12 17 20 
10 mM dNTPs 1.25 9 21.25 25 






forward primer 0.25 3 4.25 5 
backward primer 0.25 3 4.25 5 
Vent polymerase 0.25 3 4.25 5 
*all volumes in µL     9. Centrifuge your original samples for 2 minutes at maximum speed to pellet bacterial cell debris.  DNA will be in the supernatant. 10. During centrifugation, pipette 23µL of the PCR mastermix into 11 new PCR tubes. 11. After centrifugation, pipette 2µL of supernatant from each of the 10 samples into one of the PCR reaction tubes. 12. The  11th  PCR  reaction  tube  will  be  your  positive  control.    Add  0.5µL  of  the  PCR template that you originally cloned or subcloned your inserted gene from and 1.5µL of dH2O. 13. Perform a PCR reaction as usual.   For best results,  increase the number of cycles in the PCR reaction.  For example, if 25 cycles were used in the cloning reaction, use 30‐35 in the colony PCR reaction. 14. After  the PCR  reaction has  completed,  run all  of  the  samples on a 1% agarose gel.  Positive results will have a band matching the band in the positive control. 15. Positive results should be confirmed by DNA Sequencing.   In the afternoon, remove plates from the incubator, and inoculate overnight liquid cultures as usual using the colonies that tested positive. 16. The next day, perform a DNA miniprep and DNA sequencing as usual. 









1 ACGTTATCGA CTGCACGGTG CACCAATGCT TCTGGCGTCA GGCAGCCATC GGAAGCTGTG 
 61 GTATGGCTGT GCAGGTCGTA AATCACTGCA TAATTCGTGT CGCTCAAGGC GCACTCCCGT 
121 TCTGGATAAT GTTTTTTGCG CCGACATCAT AACGGTTCTG GCAAATATTC TGAAATGAGC 
181 TGTTGACAAT TAATCATCGG CTCGTATAAT GTGTGGAATT GTGAGCGGAT AACAATTTCA 
241 CACAGGAAAC AGTATTCATG TCCCCTATAC TAGGTTATTG GAAAATTAAG GGCCTTGTGC 
301 AACCCACTCG ACTTCTTTTG GAATATCTTG AAGAAAAATA TGAAGAGCAT TTGTATGAGC 
361 GCGATGAAGG TGATAAATGG CGAAACAAAA AGTTTGAATT GGGTTTGGAG TTTCCCAATC 
421 TTCCTTATTA TATTGATGGT GATGTTAAAT TAACACAGTC TATGGCCATC ATACGTTATA 
481 TAGCTGACAA GCACAACATG TTGGGTGGTT GTCCAAAAGA GCGTGCAGAG ATTTCAATGC 
541 TTGAAGGAGC GGTTTTGGAT ATTAGATACG GTGTTTCGAG AATTGCATAT AGTAAAGACT 
601 TTGAAACTCT CAAAGTTGAT TTTCTTAGCA AGCTACCTGA AATGCTGAAA ATGTTCGAAG 
661 ATCGTTTATG TCATAAAACA TATTTAAATG GTGATCATGT AACCCATCCT GACTTCATGT 
721 TGTATGACGC TCTTGATGTT GTTTTATACA TGGACCCAAT GTGCCTGGAT GCGTTCCCAA 
781 AATTAGTTTG TTTTAAAAAA CGTATTGAAG CTATCCCACA AATTGATAAG TACTTGAAAT 
841 CCAGCAAGTA TATAGCATGG CCTTTGCAGG GCTGGCAAGC CACGTTTGGT GGTGGCGACC 
901 ATCCTCCAAA ATCGGATCTG GAAGTTCTGT TCCAGGGGCC CCTGGGATCC CCAGGAATTC 
961 CCGGGTCGAC TCGAGCGGCC GCATCGTGAC TGACTGACGA TCTGCCTCGC GCGTTTCGGT 
1021 GATGACGGTG AAAACCTCTG ACACATGCAG CTCCCGGAGA CGGTCACAGC TTGTCTGTAA 
1081 GCGGATGCCG GGAGCAGACA AGCCCGTCAG GGCGCGTCAG CGGGTGTTGG CGGGTGTCGG 
1141 GGCGCAGCCA TGACCCAGTC ACGTAGCGAT AGCGGAGTGT ATAATTCTTG AAGACGAAAG 
1201 GGCCTCGTGA TACGCCTATT TTTATAGGTT AATGTCATGA TAATAATGGT TTCTTAGACG 
1261 TCAGGTGGCA CTTTTCGGGG AAATGTGCGC GGAACCCCTA TTTGTTTATT TTTCTAAATA 
1321 CATTCAAATA TGTATCCGCT CATGAGACAA TAACCCTGAT AAATGCTTCA ATAATATTGA 
1381 AAAAGGAAGA GTATGAGTAT TCAACATTTC CGTGTCGCCC TTATTCCCTT TTTTGCGGCA 
1441 TTTTGCCTTC CTGTTTTTGC TCACCCAGAA ACGCTGGTGA AAGTAAAAGA TGCTGAAGAT 
1501 CAGTTGGGTG CACGAGTGGG TTACATCGAA CTGGATCTCA ACAGCGGTAA GATCCTTGAG 
1561 AGTTTTCGCC CCGAAGAACG TTTTCCAATG ATGAGCACTT TTAAAGTTCT GCTATGTGGC 
1621 GCGGTATTAT CCCGTGTTGA CGCCGGGCAA GAGCAACTCG GTCGCCGCAT ACACTATTCT 
1681 CAGAATGACT TGGTTGAGTA CTCACCAGTC ACAGAAAAGC ATCTTACGGA TGGCATGACA 
1741 GTAAGAGAAT TATGCAGTGC TGCCATAACC ATGAGTGATA ACACTGCGGC CAACTTACTT 
1801 CTGACAACGA TCGGAGGACC GAAGGAGCTA ACCGCTTTTT TGCACAACAT GGGGGATCAT 
1861 GTAACTCGCC TTGATCGTTG GGAACCGGAG CTGAATGAAG CCATACCAAA CGACGAGCGT 






1921 GACACCACGA TGCCTGCAGC AATGGCAACA ACGTTGCGCA AACTATTAAC TGGCGAACTA 
1981 CTTACTCTAG CTTCCCGGCA ACAATTAATA GACTGGATGG AGGCGGATAA AGTTGCAGGA 
2041 CCACTTCTGC GCTCGGCCCT TCCGGCTGGC TGGTTTATTG CTGATAAATC TGGAGCCGGT 
2101 GAGCGTGGGT CTCGCGGTAT CATTGCAGCA CTGGGGCCAG ATGGTAAGCC CTCCCGTATC 
2161 GTAGTTATCT ACACGACGGG GAGTCAGGCA ACTATGGATG AACGAAATAG ACAGATCGCT 
2221 GAGATAGGTG CCTCACTGAT TAAGCATTGG TAACTGTCAG ACCAAGTTTA CTCATATATA 
2281 CTTTAGATTG ATTTAAAACT TCATTTTTAA TTTAAAAGGA TCTAGGTGAA GATCCTTTTT 
2341 GATAATCTCA TGACCAAAAT CCCTTAACGT GAGTTTTCGT TCCACTGAGC GTCAGACCCC 
2401 GTAGAAAAGA TCAAAGGATC TTCTTGAGAT CCTTTTTTTC TGCGCGTAAT CTGCTGCTTG 
2461 CAAACAAAAA AACCACCGCT ACCAGCGGTG GTTTGTTTGC CGGATCAAGA GCTACCAACT 
2521 CTTTTTCCGA AGGTAACTGG CTTCAGCAGA GCGCAGATAC CAAATACTGT CCTTCTAGTG 
2581 TAGCCGTAGT TAGGCCACCA CTTCAAGAAC TCTGTAGCAC CGCCTACATA CCTCGCTCTG 
2641 CTAATCCTGT TACCAGTGGC TGCTGCCAGT GGCGATAAGT CGTGTCTTAC CGGGTTGGAC 
2701 TCAAGACGAT AGTTACCGGA TAAGGCGCAG CGGTCGGGCT GAACGGGGGG TTCGTGCACA 
2761 CAGCCCAGCT TGGAGCGAAC GACCTACACC GAACTGAGAT ACCTACAGCG TGAGCTATGA 
2821 GAAAGCGCCA CGCTTCCCGA AGGGAGAAAG GCGGACAGGT ATCCGGTAAG CGGCAGGGTC 
2881 GGAACAGGAG AGCGCACGAG GGAGCTTCCA GGGGGAAACG CCTGGTATCT TTATAGTCCT 
2941 GTCGGGTTTC GCCACCTCTG ACTTGAGCGT CGATTTTTGT GATGCTCGTC AGGGGGGCGG 
3001 AGCCTATGGA AAAACGCCAG CAACGCGGCC TTTTTACGGT TCCTGGCCTT TTGCTGGCCT 
3061 TTTGCTCACA TGTTCTTTCC TGCGTTATCC CCTGATTCTG TGGATAACCG TATTACCGCC 
3121 TTTGAGTGAG CTGATACCGC TCGCCGCAGC CGAACGACCG AGCGCAGCGA GTCAGTGAGC 
3181 GAGGAAGCGG AAGAGCGCCT GATGCGGTAT TTTCTCCTTA CGCATCTGTG CGGTATTTCA 
3241 CACCGCATAA ATTCCGACAC CATCGAATGG TGCAAAACCT TTCGCGGTAT GGCATGATAG 
3301 CGCCCGGAAG AGAGTCAATT CAGGGTGGTG AATGTGAAAC CAGTAACGTT ATACGATGTC 
3361 GCAGAGTATG CCGGTGTCTC TTATCAGACC GTTTCCCGCG TGGTGAACCA GGCCAGCCAC 
3421 GTTTCTGCGA AAACGCGGGA AAAAGTGGAA GCGGCGATGG CGGAGCTGAA TTACATTCCC 
3481 AACCGCGTGG CACAACAACT GGCGGGCAAA CAGTCGTTGC TGATTGGCGT TGCCACCTCC 
3541 AGTCTGGCCC TGCACGCGCC GTCGCAAATT GTCGCGGCGA TTAAATCTCG CGCCGATCAA 
3601 CTGGGTGCCA GCGTGGTGGT GTCGATGGTA GAACGAAGCG GCGTCGAAGC CTGTAAAGCG 
3661 GCGGTGCACA ATCTTCTCGC GCAACGCGTC AGTGGGCTGA TCATTAACTA TCCGCTGGAT 
3721 GACCAGGATG CCATTGCTGT GGAAGCTGCC TGCACTAATG TTCCGGCGTT ATTTCTTGAT 
3781 GTCTCTGACC AGACACCCAT CAACAGTATT ATTTTCTCCC ATGAAGACGG TACGCGACTG 
3841 GGCGTGGAGC ATCTGGTCGC ATTGGGTCAC CAGCAAATCG CGCTGTTAGC GGGCCCATTA 
3901 AGTTCTGTCT CGGCGCGTCT GCGTCTGGCT GGCTGGCATA AATATCTCAC TCGCAATCAA 
3961 ATTCAGCCGA TAGCGGAACG GGAAGGCGAC TGGAGTGCCA TGTCCGGTTT TCAACAAACC 
4021 ATGCAAATGC TGAATGAGGG CATCGTTCCC ACTGCGATGC TGGTTGCCAA CGATCAGATG 
4081 GCGCTGGGCG CAATGCGCGC CATTACCGAG TCCGGGCTGC GCGTTGGTGC GGATATCTCG 
4141 GTAGTGGGAT ACGACGATAC CGAAGACAGC TCATGTTATA TCCCGCCGTC AACCACCATC 
4201 AAACAGGATT TTCGCCTGCT GGGGCAAACC AGCGTGGACC GCTTGCTGCA ACTCTCTCAG 
4261 GGCCAGGCGG TGAAGGGCAA TCAGCTGTTG CCCGTCTCAC TGGTGAAAAG AAAAACCACC 
4321 CTGGCGCCCA ATACGCAAAC CGCCTCTCCC CGCGCGTTGG CCGATTCATT AATGCAGCTG 






4381 GCACGACAGG TTTCCCGACT GGAAAGCGGG CAGTGAGCGC AACGCAATTA ATGTGAGTTA 
4441 GCTCACTCAT TAGGCACCCC AGGCTTTACA CTTTATGCTT CCGGCTCGTA TGTTGTGTGG 
4501 AATTGTGAGC GGATAACAAT TTCACACAGG AAACAGCTAT GACCATGATT ACGGATTCAC 
4561 TGGCCGTCGT TTTACAACGT CGTGACTGGG AAAACCCTGG CGTTACCCAA CTTAATCGCC 
4621 TTGCAGCACA TCCCCCTTTC GCCAGCTGGC GTAATAGCGA AGAGGCCCGC ACCGATCGCC 
4681 CTTCCCAACA GTTGCGCAGC CTGAATGGCG AATGGCGCTT TGCCTGGTTT CCGGCACCAG 
4741 AAGCGGTGCC GGAAAGCTGG CTGGAGTGCG ATCTTCCTGA GGCCGATACT GTCGTCGTCC 
4801 CCTCAAACTG GCAGATGCAC GGTTACGATG CGCCCATCTA CACCAACGTA ACCTATCCCA 
4861 TTACGGTCAA TCCGCCGTTT GTTCCCACGG AGAATCCGAC GGGTTGTTAC TCGCTCACAT 




10         20         30         40         50         60  
MIKLGIVMDP IANINIKKDS SFAMLLEAQR RGYELHYMEM ADLYLINGEA RARTHTLSVE  
 
        70         80         90        100        110        120  
QNYDKWYEFT GEQDLPLADL DVILMRKDPP FDTEFIYATY ILERAEDKGT LIVNKPQSLR  
 
       130        140        150        160        170        180  
DCNEKLFTAW FSDLTPETLV TRNKAQLKAF WEKHSDIILK PLDGMGGASI FRVKEGDPNL  
 
       190        200        210        220        230        240  
GVIAETLTEH GTRYCMAQNY LPAIKDGDKR VLVVDGEPVP YCLARIPQGG ETRGNLAAGG  
 
       250        260        270        280        290        300  
RGEPRPLTES DWKIARQIGP TLKEKGLIFV GLDIIGDRLT EINVTSPTCI REIEAEFPVS  
 
       310  
ITGMLMDAIE ARLQQQ 
 Number of amino acids: 316 Molecular weight: 35560.9 Theoretical pI: 5.11 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Einsichten in diese Bindung.  Beide  Proteine  sind  essentielle  Bestandteile  der  extrazellulären  Matrix  und spielen  im  Wachstum,bei  der  Krebs‐Tumor  Progression  sowie  beim  Aufbau  und  der Heilung von Wunden eine große Rolle. Collagen hat zwei α1 und einen α2 Stränge. An jedem  wurden  zwei  Bindungsseiten  für  Fibronectin  gefunden.  Diese  beiden Interaktionsseiten  werden  collagenase‐site  und  260‐site  genannt.  Während  meiner Arbeit untersuchte  ich  im Speziellen die Bindung dieser vier Seiten – collagenase‐site‐
α1, collagenase‐site‐α2, 260‐site‐α1 and 260‐site‐α2 ‐ mit dem Fibronectin Fragment 8‐9FnI. Die  Interaktionen wurden mittels Nuclear Magnetic Resonance  (NMR) und  x‐ray Kristallographie  untersucht.  Als  Neben‐Projekt  versuchte  ich  ein  tripel‐helikales Collagenpeptid eigenständig herzustellen. Aus der Interaktions‐Analyse konnten drei wichtige Schlussfolgerungen gezogen werden.  Zuerst  wurde  die  Interaktion  von  Collagen  Typ  1  α2‐Stang  mit  dem  8‐9FnI‐Fragment  mittels  NMR  analysiert.  Man  konnten  eine  sehr  schwache  Bindung  beider Interaktionsseiten  zu  Fibronectin  feststellen.  Sodann  wurde  die  Interaktion  zwischen Collagen  Typ  1  260‐site‐α1  8‐9FnI‐Fragment  charakterisiert.  Für  die  Struktur‐Determination und der Feststellung der Stärke der Bindung wurden Methoden der NMR und der X‐ray Kristallographie angewendet. Jene Interaktion beeinflusst die Fibronectin‐Collagen Bindung. Es  liegt  eine  schwache Bindung vor. Die Struktur konnte auf Grund von Kristallen,  bei  einer Auflösung von 2.6Å und mittels molecular  replacement  gelöst werden  (Abbildung  1).  Dr.  Ioannis  Vakonakis  beschäftigte  sich  schon  länger  mit  der Interaktion  von  Fibronectin  in  der  extrazellulären  Martix.  So  konnten  Drs.  Ioannis Vakonakis  und  Michèle  Erat  bereits  die  Struktur  des  Interaktions‐Komplexes collagenase‐site‐α1 mit 8‐9FnI determinieren (Erat, Slatter et al. 2009). Ich nutzte diese Information und verwendetes sie für molecular replacement. Ferner untersuchte ich den Interaktions‐Komplex collagenase‐site‐α1 mit  8‐9FnI. Hier  liegt, wie bereits untersucht, 






eine starke Bindung vor. Bis jetzt war jedoch noch nicht klar, weshalb diese Bindung so stabil  sei.  Mittels  NMR‐Untersuchungen  und  Fluorescence  Anisotropie  Messungen konnte verifizieren werden, dass es sich um eine sequenzielles Phänomen handelt. Die hydrophobe Aminosäure Valin 273 ist hierfür verantwortlich. Als  zweites Projekt versuchte  ich ein  tripel‐helikales Collagenpeptid mittels Methoden der  Polymerase‐Chain‐Reaction  (PCR),  bakterieller  Expression  und  diverser Aufreinigungs‐Schirtte  herzustellen.  Ziel  war  der  Versuch  schnell  und  kostengünstig diese Peptide herzustellen um sie später für NMR‐Analysen zu verwenden. Dies gelang und es konnte mittels Circular Dichrosim (CD) uns Massenspektroskopie‐Analysen die tripel‐helikale Formation nachweisen. Voraussichtlich im November 2009 wird ein Publikation über jene Interaktionen, von 8‐9FnI Fibronectin Fragment mit Collagen Typ 1, erschienen.    
    
 
Abbildung  1:  Interaktion‐Komplex  von  260‐site‐α1  mit  8‐9Fn1  (resolution 2.6Å, space group P3121, 2 copies/AU, 2.6 Å, Rwork 22.3%, Rfree 27.1% ) In grün ist das 8‐9Fn1 Fibronectin‐Fragment   und in blau die Collagen Typ 1 260‐site‐α1 gezeigt. 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